rfhg_112766.1

Basic information about the TSS

---

TSS ID: rfhg_112766.1 Species: human Chr: chr8		Start: 144790386 End: 144790466 Strand: -
Source datasets	PRJNA401781
Protocol	oligo_capping
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	pELS (EH38D4163360,EH38E2676591)
Category:	pELS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000534781.1:-406 GeneID: 6132 HGNC/MGI_ID: HGNC:10368 UniProt_ID: Nearer transcript ids and distances:

Gene_name: MIR6850 Gene_symbol: RPL8 Gene_synonyms: L8 Gene_source: HGNC:10368

TATA-Box annotation

---

Distance to TSS:	1565
Nearest PromoterID:	NR_106909
Entrez ID:	102465978
Nearest Unigene:
Nearest Refseq:	NR_106909
Nearest Ensembl:	ENSG00000283764
Gene Name:	MIR6850
Gene Alias:	hsa-mir-6850
Gene Type:	ncRNA
CpG%:	0.037500
GC%:	0.543210
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@RPL8 p2@RPL8 p3@RPL8 p4@RPL8
Sample		p1@RPL8	p2@RPL8	p3@RPL8	p4@RPL8
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	1298.36	28.25	3.12	5.65
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	1447.39	28.93	3.03	4.86
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	1385.82	27.97	2.70	4.82
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	1303.60	22.45	1.04	1.66
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	1353.40	25.65	1.12	4.05
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	1168.68	30.04	2.13	2.52
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	1210.56	35.30	2.40	6.32
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	1490.86	30.52	2.66	6.54
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	1603.73	33.34	2.14	4.70
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	1419.50	26.66	4.06	4.06
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	1321.85	27.49	2.02	5.66
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	1140.38	26.43	0.41	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	885.92	11.12	1.29	3.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	738.37	9.92	1.20	5.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	801.59	8.34	2.42	3.51
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	801.00	11.82	1.51	7.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	814.00	10.05	0.87	3.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	828.87	10.97	0.84	4.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	784.27	6.40	2.13	1.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	936.05	13.39	2.71	6.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	795.63	12.56	1.60	4.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	809.78	13.98	1.21	7.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	681.57	11.76	2.07	5.43
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	815.61	12.86	1.46	2.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	829.44	14.45	1.55	5.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	969.16	12.66	2.53	6.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	836.83	10.99	4.40	6.04
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	970.59	10.14	2.36	5.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	1007.26	12.11	2.58	4.04
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	855.24	8.32	1.81	5.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	905.20	16.12	2.30	3.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	984.92	9.77	1.37	4.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	951.74	13.51	1.06	5.28
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	961.76	10.72	2.64	7.09
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	881.10	10.66	1.50	7.11
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	918.64	12.07	2.87	3.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	937.29	12.06	2.86	3.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	934.90	8.46	1.61	5.04
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	968.05	8.91	2.70	5.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	828.93	6.72	2.40	3.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	889.99	11.76	0.94	2.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	832.10	9.37	2.64	4.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	860.87	11.81	2.32	5.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	882.18	9.27	2.80	4.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	880.19	10.24	0.80	4.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	938.50	9.07	4.42	6.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	983.86	9.60	3.60	3.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	981.48	8.05	2.68	2.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	991.97	13.64	3.59	3.83
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	901.80	12.54	2.43	5.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	1074.78	13.32	3.89	9.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	1230.62	13.56	3.78	6.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	363.80	13.99	0.00	27.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	1464.14	13.48	2.48	6.74
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	1534.97	12.92	2.32	7.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	880.05	5.87	5.87	10.91
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	1129.74	5.97	5.51	15.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	1577.11	7.78	4.54	8.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	1554.78	10.60	0.64	3.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	1093.56	8.49	3.14	8.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	1376.27	11.99	1.41	2.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	1318.97	12.90	3.93	3.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	817.64	3.98	5.57	5.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	1029.50	5.44	5.44	4.76
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	1508.61	7.15	2.27	1.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	1328.33	7.45	1.06	5.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	387.93	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	339.59	23.69	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	969.67	7.80	2.44	4.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	892.57	9.92	1.98	3.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	969.66	10.32	2.35	3.28
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	879.64	5.63	1.99	4.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	983.71	6.19	2.17	6.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	1023.94	10.09	1.53	2.14
Adipocyte - breast, donor1	11376-118A8	267.67	8.39	0.79	1.11
Adipocyte - breast, donor2	11327-117E4	310.59	4.65	1.76	3.21
Adipocyte - omental, donor1	11473-119C6	233.46	6.36	0.51	1.15
Adipocyte - omental, donor2	11474-119C7	568.09	2.99	0.75	2.24
Adipocyte - omental, donor3	11475-119C8	617.93	2.34	4.02	4.35
Adipocyte - perirenal, donor1	11476-119C9	629.70	3.83	2.55	2.55
Adipocyte - subcutaneous, donor1	11259-116F8	659.70	4.40	0.00	1.10
Adipocyte - subcutaneous, donor2	11336-117F4	629.11	7.23	0.90	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	687.80	6.95	1.04	3.82
Adipocyte differentiation, day04, donor1	13019-139D4	353.40	5.67	0.78	0.78
Adipocyte differentiation, day04, donor2	13022-139D7	422.62	6.18	0.77	0.26
Adipocyte differentiation, day04, donor3	13025-139E1	521.30	7.81	0.84	0.56
Adipocyte differentiation, day04, donor4	13028-139E4	423.22	2.94	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	290.12	5.39	0.80	1.29
Adipocyte differentiation, day08, donor2	13023-139D8	404.41	2.58	0.65	2.58
Adipocyte differentiation, day08, donor3	13026-139E2	381.23	3.73	1.60	3.20
Adipocyte differentiation, day08, donor4	13029-139E5	295.47	1.11	0.00	1.11
Adipocyte differentiation, day12, donor1	13021-139D6	442.51	6.24	2.50	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	311.70	2.26	0.00	0.75
Adipocyte differentiation, day12, donor3	13027-139E3	359.64	4.25	0.33	1.64
Adipocyte differentiation, day12, donor4	13030-139E6	233.23	2.44	0.00	0.30
Alveolar Epithelial Cells, donor1	11510-119G7	882.89	26.30	0.66	1.99
Alveolar Epithelial Cells, donor2	11590-120G6	2978.38	36.58	7.89	5.38
Alveolar Epithelial Cells, donor3	11671-122G6	807.46	15.57	1.20	4.79
Amniotic Epithelial Cells, donor1	11533-120A3	830.98	12.23	0.90	1.44
Amniotic Epithelial Cells, donor2	11613-122A2	1312.02	11.71	1.67	5.02
Amniotic Epithelial Cells, donor3	11694-123A2	503.35	20.54	2.26	1.64
Anulus Pulposus Cell, donor1	11248-116E6	476.81	10.30	0.80	2.29
Anulus Pulposus Cell, donor2	11463-119B5	786.40	3.92	2.20	1.47
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	629.01	4.94	4.49	3.59
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	634.71	6.08	5.64	3.04
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	567.17	4.28	12.84	2.14
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	550.91	4.78	2.39	5.08
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	734.76	8.85	3.79	10.12
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	588.12	11.88	3.30	12.54
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	578.30	5.20	2.27	2.92
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	686.41	5.83	3.40	4.37
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	509.55	7.72	4.75	6.53
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	610.91	7.16	1.88	3.39
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	601.58	6.53	2.90	2.90
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	583.01	8.78	5.02	6.27
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	366.70	11.20	0.66	1.98
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	428.55	4.09	2.73	1.36
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	512.24	11.91	1.81	1.66
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	564.18	3.21	1.07	3.75
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	539.22	6.80	1.89	4.53
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	434.87	8.82	3.21	5.08
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	371.65	3.90	0.00	2.93
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	541.37	4.64	1.82	2.65
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	488.69	7.20	3.60	3.60
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	428.36	3.54	0.00	3.54
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	513.90	5.66	1.37	2.40
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	406.91	4.19	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	658.24	7.28	4.85	3.88
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	645.07	7.59	1.52	5.31
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	541.48	9.69	4.85	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	694.30	5.13	2.85	4.56
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	545.13	6.20	2.14	4.06
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	496.31	9.81	1.81	4.13
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	680.82	4.22	2.82	2.35
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	575.90	4.82	2.89	2.89
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	597.87	9.99	2.14	5.71
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	642.86	3.51	2.92	5.26
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	555.18	6.62	2.11	3.91
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	754.37	14.26	4.75	10.69
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	707.41	10.17	5.09	6.61
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	596.48	5.60	3.31	5.86
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	592.16	7.62	3.81	5.72
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	631.77	5.18	1.73	2.59
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	561.39	7.62	3.39	2.54
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	513.27	6.96	2.61	2.90
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	508.27	1.89	0.94	0.94
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	556.72	6.61	1.19	3.22
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	597.62	13.90	2.32	4.63
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	447.87	2.11	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	652.03	6.00	2.57	1.72
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	502.39	5.41	4.81	3.01
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	659.72	6.56	5.10	5.83
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	659.30	8.05	3.22	4.14
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	451.40	10.20	2.55	2.55
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	487.11	9.15	1.02	1.53
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	538.81	5.78	1.86	2.06
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	546.82	11.02	2.75	3.37
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	692.64	4.78	6.21	7.17
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	571.65	5.77	1.55	2.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	640.84	4.58	4.58	4.58
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	619.80	6.65	3.32	2.22
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	531.18	6.09	2.91	3.44
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	561.89	7.27	2.91	4.00
Astrocyte - cerebellum, donor1	11500-119F6	1057.33	11.54	1.11	2.33
Astrocyte - cerebellum, donor2	11580-120F5	1542.84	11.30	3.42	4.79
Astrocyte - cerebellum, donor3	11661-122F5	1013.50	10.70	1.26	1.89
Astrocyte - cerebral cortex, donor1	11235-116D2	744.93	9.41	1.39	1.74
Astrocyte - cerebral cortex, donor2	11316-117D2	738.17	25.40	2.26	3.56
Astrocyte - cerebral cortex, donor3	11392-118C6	750.28	18.50	1.79	1.64
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	622.74	12.39	2.41	3.44
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	625.53	16.29	2.00	3.13
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	521.19	14.79	1.59	3.30
Basophils, donor1	12241-129G9	557.85	3.40	0.78	1.57
Basophils, donor2	12242-129H1	335.90	0.00	0.36	0.72
Basophils, donor3	12243-129H2	414.68	3.38	0.29	0.59
Bronchial Epithelial Cell, donor1	11511-119G8	1179.56	20.48	1.72	1.94
Bronchial Epithelial Cell, donor2	11591-120G7	3081.43	25.60	7.31	6.86
Bronchial Epithelial Cell, donor3	11672-122G7	1384.50	7.17	7.17	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	1373.30	25.11	6.90	5.02
Bronchial Epithelial Cell, donor5	11457-119A8	1408.45	21.42	3.95	3.95
Bronchial Epithelial Cell, donor6	11461-119B3	1417.21	18.88	4.15	7.14
Bronchial Epithelial Cell, donor7	11769-123I5	979.98	14.04	2.88	6.30
Burkitt's lymphoma cell line:DAUDI	10422-106C8	908.54	25.15	1.65	1.75
Burkitt's lymphoma cell line:RAJI	10476-106I8	1283.07	34.94	2.56	3.03
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	1182.85	9.59	1.92	2.88
CD133+ stem cells - cord blood derived, pool1	12223-129E9	1613.34	10.34	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	306.57	2.82	0.56	0.56
CD14+ Monocytes, donor2	11305-117B9	362.29	1.86	1.48	0.74
CD14+ Monocytes, donor3	11381-118B4	525.57	3.73	1.54	1.54
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	232.10	0.85	0.28	0.57
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	263.08	1.52	0.38	0.76
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	229.13	0.99	0.99	0.66
CD14+ monocytes - mock treated, donor1	11863-125A9	439.43	2.89	1.59	6.79
CD14+ monocytes - mock treated, donor2	11873-125C1	706.38	4.83	1.81	4.83
CD14+ monocytes - mock treated, donor3	11883-125D2	491.08	1.18	1.66	2.61
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	359.74	1.84	1.00	5.36
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	568.03	3.86	1.10	4.69
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	456.44	1.98	0.74	2.23
CD14+ monocytes - treated with BCG, donor1	11860-125A6	364.19	1.76	1.37	3.92
CD14+ monocytes - treated with BCG, donor2	11870-125B7	496.40	1.60	0.53	3.38
CD14+ monocytes - treated with BCG, donor3	11880-125C8	585.21	1.96	2.18	4.13
CD14+ monocytes - treated with Candida, donor1	11868-125B5	378.35	1.40	1.17	3.51
CD14+ monocytes - treated with Candida, donor2	11878-125C6	734.49	2.11	1.58	3.70
CD14+ monocytes - treated with Candida, donor3	11888-125D7	402.70	2.22	2.22	3.33
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	372.17	2.23	2.38	5.06
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	625.78	2.79	0.60	3.19
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	536.74	2.08	1.46	2.50
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	459.63	2.75	2.29	5.95
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	669.56	2.26	1.36	2.04
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	449.12	0.44	1.75	2.18
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	407.79	3.23	0.81	3.77
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	567.87	1.40	2.09	4.88
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	502.46	1.26	2.52	2.52
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	403.25	1.10	0.55	3.86
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	579.48	2.11	1.06	3.87
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	417.67	1.75	3.51	3.07
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	374.56	2.44	1.92	3.14
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	681.66	3.72	1.49	6.32
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	561.72	0.22	1.51	6.68
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	385.33	2.05	1.64	3.28
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	592.48	1.85	0.70	2.09
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	449.14	1.39	1.16	2.09
CD14+CD16+ Monocytes, donor1	11789-124B7	1006.78	5.67	2.18	5.89
CD14+CD16+ Monocytes, donor2	11801-124D1	799.70	3.93	2.54	6.70
CD14+CD16+ Monocytes, donor3	11912-125G4	622.99	2.38	0.87	1.52
CD14+CD16- Monocytes, donor1	11788-124B6	662.75	5.29	1.40	3.89
CD14+CD16- Monocytes, donor2	11799-124C8	639.37	2.97	1.92	2.97
CD14+CD16- Monocytes, donor3	11910-125G2	476.26	1.78	0.45	1.78
CD14-CD16+ Monocytes, donor1	11790-124B8	1133.49	6.38	2.55	2.30
CD14-CD16+ Monocytes, donor2	11800-124C9	898.02	3.29	2.85	6.37
CD14-CD16+ Monocytes, donor3	11911-125G3	862.61	2.32	0.84	2.11
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	1416.52	4.06	8.13	6.10
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	1510.54	2.03	2.71	10.17
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	1548.22	5.18	4.14	6.21
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	1106.05	6.40	2.67	1.60
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	1421.12	3.22	3.75	9.11
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	1442.48	2.11	2.11	5.62
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	1596.16	4.71	3.92	8.63
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	1949.74	5.27	3.95	7.91
CD19+ B Cells, donor1	11544-120B5	1907.63	2.47	1.64	7.40
CD19+ B Cells, donor2	11624-122B4	1450.13	1.45	3.63	3.63
CD19+ B Cells, donor3	11705-123B4	1808.29	6.06	5.55	5.55
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	742.66	10.91	1.21	1.21
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	718.28	5.99	0.80	0.40
CD34+ Progenitors, donor1	11545-120B6	986.98	4.02	6.02	0.00
CD34+ Progenitors, donor2	11625-122B5	1174.18	4.49	0.56	1.69
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	1037.46	17.28	0.75	0.75
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	1366.20	18.04	1.80	4.96
CD4+ T Cells, donor1	11225-116C1	845.87	1.07	1.79	0.71
CD4+ T Cells, donor2	11306-117C1	1033.06	1.84	7.35	12.25
CD4+ T Cells, donor3	11382-118B5	919.86	0.30	2.13	8.54
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	1120.49	1.53	1.79	6.64
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	967.12	2.70	1.35	2.25
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	858.07	2.01	1.44	3.45
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	2544.45	2.37	3.79	14.70
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	2531.17	4.21	3.51	9.13
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	2712.79	0.00	0.00	6.59
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	660.58	0.72	1.45	4.34
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	611.25	2.88	3.22	5.42
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	496.67	1.77	1.45	3.87
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	1525.56	3.59	4.48	8.07
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	1535.91	2.10	2.45	6.99
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	1088.95	0.00	0.88	6.60
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	807.86	1.69	0.42	2.53
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	638.27	2.29	2.08	4.99
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	723.72	2.34	1.34	3.34
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	1495.91	0.00	1.36	9.79
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	1984.08	1.07	4.82	12.86
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	1972.55	0.00	7.17	7.17
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	840.55	3.71	0.74	1.85
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	763.58	2.38	0.22	2.60
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	635.08	1.89	1.05	2.94
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	1587.09	3.54	4.04	10.62
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	1428.00	0.87	1.73	4.77
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	1358.00	0.44	2.18	6.97
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	1299.53	1.48	3.46	5.44
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	1638.65	1.85	0.92	5.54
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	1501.91	1.40	0.00	1.40
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	2381.31	0.55	0.83	4.43
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	2493.66	0.00	3.68	4.66
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	808.50	6.16	0.00	6.16
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	1179.64	0.36	3.22	8.24
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	1573.35	2.77	0.00	5.54
CD8+ T Cells, donor1	11226-116C2	588.66	0.65	0.65	1.31
CD8+ T Cells, donor2	11307-117C2	653.25	1.88	4.13	4.88
CD8+ T Cells, donor3	11383-118B6	1074.09	2.78	2.52	5.81
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	1070.34	13.76	0.00	3.44
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	904.65	11.02	2.16	2.16
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	738.70	10.40	1.37	3.28
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	1018.62	10.51	0.90	4.50
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	922.97	13.20	1.68	2.64
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	967.53	11.14	1.14	1.82
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	1080.55	15.21	1.74	2.82
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	1052.29	20.00	0.53	3.95
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	1016.86	18.06	3.05	3.52
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	1167.36	21.43	0.91	3.92
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	956.05	14.82	2.91	3.78
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	859.78	18.12	1.33	3.46
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	664.07	3.94	0.44	1.75
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	743.72	3.64	0.00	1.82
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	487.05	4.48	0.00	2.24
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	1050.57	11.16	0.36	2.16
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	955.24	14.39	1.15	1.73
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	704.73	9.19	0.47	1.41
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	895.25	18.06	1.27	4.12
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	915.31	13.84	1.54	2.77
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	810.43	12.18	0.64	2.56
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	990.20	20.27	1.53	2.29
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	960.43	15.76	0.79	1.97
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	990.90	15.13	1.51	0.76
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	707.40	5.62	2.41	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	630.19	6.99	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	823.44	7.01	0.00	2.00
Cardiac Myocyte, donor1	11525-119I4	473.38	3.66	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	821.18	10.87	1.98	2.96
Cardiac Myocyte, donor3	11686-122I3	680.75	22.31	0.32	0.63
Chondrocyte - de diff, donor1	11261-116G1	626.08	3.12	0.69	0.69
Chondrocyte - de diff, donor2	11338-117F6	695.12	7.46	1.07	0.71
Chondrocyte - de diff, donor3	11410-118E6	444.31	5.35	1.59	3.87
Chondrocyte - re diff, donor2	11339-117F7	489.71	5.37	1.79	2.69
Chondrocyte - re diff, donor3	11411-118E7	513.59	6.07	1.21	0.81
Ciliary Epithelial Cells, donor1	11242-116D9	491.05	6.89	1.38	1.72
Ciliary Epithelial Cells, donor2	11323-117D9	618.42	25.22	3.42	3.42
Ciliary Epithelial Cells, donor3	11399-118D4	580.37	17.79	1.33	3.63
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	327.65	6.88	0.64	0.83
Corneal Epithelial Cells, donor1	11526-119I5	1231.14	27.45	0.88	1.54
Corneal Epithelial Cells, donor2	11606-120I4	1254.77	28.44	3.41	5.69
Corneal Epithelial Cells, donor3	11687-122I4	1166.95	30.42	2.81	6.14
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	196.96	10.90	0.33	0.50
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	213.85	11.67	0.63	1.58
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	279.51	17.25	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	227.32	5.83	0.97	0.76
Dendritic Cells - plasmacytoid, donor1	11228-116C4	461.22	0.68	0.68	2.73
Dendritic Cells - plasmacytoid, donor2	11309-117C4	475.94	1.31	1.96	1.31
Dendritic Cells - plasmacytoid, donor3	11385-118B8	759.79	0.97	0.97	0.48
Endothelial Cells - Aortic, donor0	11207-116A1	516.15	20.35	0.17	0.67
Endothelial Cells - Aortic, donor1	11263-116G3	883.68	16.43	0.00	1.17
Endothelial Cells - Aortic, donor2	11340-117F8	696.81	16.40	0.28	1.70
Endothelial Cells - Aortic, donor3	11412-118E8	450.98	25.95	1.57	0.79
Endothelial Cells - Artery, donor1	11264-116G4	620.14	15.13	0.00	2.33
Endothelial Cells - Artery, donor2	11341-117F9	574.55	29.88	3.29	4.47
Endothelial Cells - Artery, donor3	11413-118E9	698.61	28.40	1.75	2.63
Endothelial Cells - Lymphatic, donor1	11236-116D3	271.08	7.54	1.55	0.66
Endothelial Cells - Lymphatic, donor2	11317-117D3	241.28	8.22	0.61	0.91
Endothelial Cells - Lymphatic, donor3	11393-118C7	257.38	4.79	0.28	0.28
Endothelial Cells - Microvascular, donor1	11265-116G5	875.06	7.43	0.59	1.19
Endothelial Cells - Microvascular, donor2	11342-117G1	719.04	19.79	1.56	3.64
Endothelial Cells - Microvascular, donor3	11414-118F1	612.80	13.19	1.28	3.40
Endothelial Cells - Thoracic, donor1	11266-116G6	697.01	10.80	0.40	1.20
Endothelial Cells - Thoracic, donor2	11343-117G2	702.85	22.54	2.10	6.81
Endothelial Cells - Umbilical vein, donor1	11243-116E1	425.05	21.00	1.74	1.74
Endothelial Cells - Umbilical vein, donor2	11324-117E1	555.97	15.43	0.22	0.87
Endothelial Cells - Umbilical vein, donor3	11400-118D5	628.83	29.43	0.73	1.71
Endothelial Cells - Vein, donor1	11267-116G7	784.88	21.61	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	590.23	23.05	0.00	1.40
Endothelial Cells - Vein, donor3	11416-118F3	687.22	24.49	2.04	3.61
Eosinophils, donor1	12244-129H3	594.63	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	217.83	1.65	0.00	0.00
Eosinophils, donor3	12246-129H5	174.77	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	1036.19	33.23	0.98	0.73
Esophageal Epithelial Cells, donor2	11587-120G3	2329.78	10.40	0.00	12.48
Esophageal Epithelial Cells, donor3	11668-122G3	1447.92	32.54	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	428.58	8.21	0.41	0.82
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	607.33	26.72	5.47	12.70
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	1125.52	29.47	4.23	6.83
Fibroblast - Aortic Adventitial, donor1	11245-116E3	497.01	24.62	2.06	3.03
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	199.66	6.96	0.00	0.27
Fibroblast - Aortic Adventitial, donor2	11326-117E3	548.97	13.61	2.53	4.11
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	360.72	1.84	0.26	1.05
Fibroblast - Aortic Adventitial, donor3	11401-118D6	647.46	17.61	1.33	2.99
Fibroblast - Cardiac, donor1	11268-116G8	652.77	9.98	3.18	2.27
Fibroblast - Cardiac, donor2	11345-117G4	756.43	23.50	0.00	2.27
Fibroblast - Cardiac, donor3	11417-118F4	583.08	34.22	1.42	4.73
Fibroblast - Cardiac, donor4	11452-119A3	346.45	8.49	0.61	0.61
Fibroblast - Cardiac, donor5	11456-119A7	871.45	11.42	2.66	3.17
Fibroblast - Cardiac, donor6	11460-119B2	880.91	14.86	1.97	2.43
Fibroblast - Choroid Plexus, donor1	11492-119E7	814.66	5.90	1.21	2.28
Fibroblast - Choroid Plexus, donor2	11572-120E6	638.51	10.35	1.73	2.59
Fibroblast - Choroid Plexus, donor3	11653-122E6	1034.14	23.44	1.46	5.86
Fibroblast - Conjunctival, donor1	11531-120A1	1096.46	13.15	0.46	0.92
Fibroblast - Conjunctival, donor3	11692-122I9	472.69	2.71	1.36	1.87
Fibroblast - Dermal, donor1	11269-116G9	754.59	7.51	1.17	2.58
Fibroblast - Dermal, donor2	11346-117G5	1000.43	16.98	0.94	0.94
Fibroblast - Dermal, donor3	11418-118F5	563.93	9.43	2.18	2.06
Fibroblast - Dermal, donor4	11450-119A1	977.73	12.66	3.73	3.50
Fibroblast - Dermal, donor5	11454-119A5	1151.39	10.99	2.97	4.01
Fibroblast - Dermal, donor6	11458-119A9	1193.97	13.64	2.76	2.92
Fibroblast - Gingival, donor1	11237-116D4	456.23	7.29	1.04	1.67
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	559.37	9.96	1.31	3.67
Fibroblast - Gingival, donor2	11318-117D4	530.03	7.64	3.03	4.74
Fibroblast - Gingival, donor3	11394-118C8	534.10	3.77	1.06	2.51
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	399.97	1.04	1.04	1.04
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	365.45	4.76	1.94	2.29
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	691.24	7.95	1.87	2.34
Fibroblast - Gingival, donor6 (control)	11922-125H5	633.13	7.30	1.08	2.70
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	292.54	5.65	0.35	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	598.72	9.21	1.02	2.19
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	532.19	8.59	1.09	2.18
Fibroblast - Gingival, donor8 (control)	11926-125H9	687.23	12.40	1.76	1.76
Fibroblast - Gingival, donor9 (control)	11927-125I1	536.33	1.61	3.08	1.17
Fibroblast - Lung, donor1	11270-116H1	1107.87	14.95	2.72	4.08
Fibroblast - Lung, donor2	11347-117G6	538.67	0.00	1.49	1.49
Fibroblast - Lung, donor3	11419-118F6	685.23	13.08	2.74	6.33
Fibroblast - Lymphatic, donor1	11506-119G3	903.00	11.66	1.67	0.83
Fibroblast - Lymphatic, donor2	11586-120G2	802.81	2.80	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	844.11	15.67	0.84	2.80
Fibroblast - Mammary, donor1	11540-120B1	723.03	10.96	0.81	0.81
Fibroblast - Mammary, donor2	11620-122A9	1613.66	15.98	0.00	3.99
Fibroblast - Mammary, donor3	11701-123A9	679.01	11.91	0.00	5.96
Fibroblast - Periodontal Ligament, donor1	11238-116D5	695.98	17.26	0.78	0.78
Fibroblast - Periodontal Ligament, donor2	11319-117D5	479.92	14.86	2.73	2.43
Fibroblast - Periodontal Ligament, donor3	11395-118C9	335.67	7.04	0.00	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	588.46	5.72	1.53	1.53
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	463.57	7.56	2.70	5.40
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	404.98	5.57	1.51	1.28
Fibroblast - Pulmonary Artery, donor1	11250-116E8	506.13	28.96	0.99	3.76
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	686.58	9.55	1.02	1.02
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	944.17	12.70	1.34	0.67
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	780.84	10.28	3.16	2.77
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	355.62	0.40	0.40	0.40
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	633.03	5.86	0.89	1.42
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	582.98	4.34	1.58	2.56
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	434.13	1.81	0.00	2.11
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	753.29	2.05	1.19	2.59
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	351.77	0.51	0.51	1.01
Fibroblast - skin normal, donor1	11553-120C5	621.04	3.28	0.98	0.98
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	189.48	2.81	0.40	0.20
Fibroblast - skin normal, donor2	11561-120D4	696.10	3.11	0.70	2.11
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	485.09	1.81	1.21	1.81
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	514.23	7.54	0.75	1.74
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	557.64	3.93	1.20	3.42
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	349.12	0.33	0.33	0.33
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	752.04	6.82	1.17	2.13
Fibroblast - skin walker warburg, donor1	11554-120C6	662.24	8.94	1.18	1.35
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	728.74	5.02	4.08	5.33
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	465.36	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	1078.08	3.49	1.74	2.61
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	392.65	20.11	0.17	1.04
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	387.24	21.34	0.26	1.82
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	362.06	19.67	0.77	0.51
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	2354.84	98.76	6.12	10.72
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	1999.08	102.73	9.57	17.87
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	1852.50	57.62	7.42	7.13
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	1444.14	9.38	7.72	5.52
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	994.59	13.24	5.02	3.42
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	1538.08	54.49	6.14	6.93
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	1444.33	13.22	7.67	5.55
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	1254.04	12.39	4.89	2.94
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	1674.70	62.35	7.96	9.29
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	1155.03	23.32	2.26	4.24
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	947.09	13.67	1.97	4.19
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	880.55	41.91	3.49	6.45
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	791.31	11.03	1.73	5.58
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	1029.75	16.47	1.94	4.84
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	728.64	23.99	3.46	6.91
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	671.07	9.36	2.05	2.74
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	794.73	8.22	1.74	4.61
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	746.66	11.37	1.75	2.62
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	777.11	6.50	0.59	4.73
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	795.59	6.99	0.79	3.34
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	737.73	12.51	1.12	2.01
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	598.65	5.85	2.82	3.63
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	646.17	6.28	1.19	3.05
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	412.15	9.40	0.44	1.24
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	449.52	3.95	0.52	0.52
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	604.55	3.59	0.00	0.85
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	605.50	4.09	1.55	2.21
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	402.67	7.90	0.42	1.25
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	614.79	8.17	0.41	1.23
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	623.66	5.16	2.27	4.75
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	639.19	4.38	0.58	2.08
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	508.63	7.50	1.00	2.50
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	545.13	3.97	0.44	2.42
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	689.12	3.07	1.48	5.41
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	536.20	7.46	0.81	2.59
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	688.90	5.13	1.92	4.17
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	586.34	4.26	1.04	1.99
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	536.22	6.01	1.11	1.74
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	484.41	3.65	2.13	3.04
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	541.20	5.02	1.36	2.09
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	550.20	7.03	1.54	1.98
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	441.30	5.61	1.12	2.52
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	384.42	4.54	0.19	1.94
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	351.10	6.95	2.67	2.14
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	312.28	6.89	1.07	1.07
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	448.20	7.25	0.26	1.55
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	419.08	6.23	1.08	1.63
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	369.26	4.61	0.74	1.84
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	414.06	3.29	2.41	1.32
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	240.00	2.98	0.99	0.99
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	339.01	3.30	0.79	2.11
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	375.07	3.63	0.81	2.82
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	159.36	0.51	0.25	0.25
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	1446.37	23.89	4.98	3.38
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	1174.99	28.97	3.08	5.85
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	1276.60	29.87	1.64	4.50
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	1459.19	106.71	4.38	4.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	1434.53	115.28	3.11	5.37
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	1780.71	38.74	4.15	2.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	2012.01	106.42	7.42	4.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	1479.93	53.38	2.71	6.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	1748.87	40.11	4.81	3.21
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	1957.92	39.99	5.22	6.96
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	1374.50	41.34	5.86	7.16
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	1237.05	35.41	4.12	9.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	1722.78	39.99	6.66	10.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	1260.09	33.00	4.19	5.59
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	1302.14	34.65	2.94	3.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	1472.16	20.97	5.03	5.87
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	1369.62	19.40	2.86	5.73
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	1288.00	25.47	3.06	8.49
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	1856.36	27.15	0.00	16.71
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	1563.47	16.04	4.01	5.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	1430.78	17.17	1.78	7.10
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	1506.09	42.35	3.39	3.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	1340.38	26.10	5.38	8.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	1169.75	22.09	4.37	5.52
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	2044.17	21.07	5.27	5.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	1193.60	21.14	1.92	6.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	1150.68	18.91	3.26	1.96
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	1621.27	30.77	6.69	7.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	1455.93	15.03	5.39	6.93
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	1195.11	18.14	2.40	5.14
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	1841.23	22.36	4.97	7.45
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	2020.93	13.68	4.72	9.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	1573.91	12.67	6.03	10.26
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	1988.92	19.84	7.12	8.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	1629.26	14.36	3.59	3.99
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	1627.58	11.35	7.40	9.37
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	2089.38	9.44	20.07	18.89
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	2236.35	9.92	2.92	7.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	1758.16	10.09	4.39	10.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	1407.17	6.78	3.39	12.72
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	1248.74	22.09	1.19	5.97
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	1397.51	20.87	3.88	8.73
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	817.17	11.41	1.14	3.42
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	395.44	3.74	2.49	4.16
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	468.90	12.37	1.12	3.37
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	727.88	6.03	1.90	4.76
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	895.64	12.11	1.67	4.60
Hep-2 cells mock treated, biol_rep1	11898-125E8	820.76	27.39	3.60	6.61
Hep-2 cells mock treated, biol_rep2	11899-125E9	1002.68	28.70	1.86	5.40
Hep-2 cells mock treated, biol_rep3	11900-125F1	949.14	22.52	2.96	5.01
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	812.60	31.59	4.48	7.21
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	998.91	26.43	2.36	6.23
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	902.25	23.25	2.15	6.03
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	962.05	31.88	2.99	6.73
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	906.98	24.02	2.57	5.66
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	1074.53	23.07	3.52	6.09
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	847.83	6.16	1.68	2.24
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	975.52	23.37	2.16	1.73
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	401.86	13.22	5.29	7.93
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	847.59	8.82	1.41	2.12
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	1198.02	7.27	1.45	2.18
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	701.98	17.48	1.22	4.55
Hepatocyte, donor1	11523-119I2	342.60	1.21	1.21	2.42
Hepatocyte, donor2	11603-120I1	373.84	4.31	0.00	1.08
Hepatocyte, donor3	11684-122I1	324.56	3.07	0.00	3.07
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	897.44	5.22	4.57	7.83
Intestinal epithelial cells (polarized), donor1	11246-116E4	381.20	8.39	1.22	0.87
Iris Pigment Epithelial Cells, donor1	11530-119I9	364.01	10.56	0.82	0.96
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	1423.20	25.47	0.00	12.74
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	1495.27	13.35	0.00	6.68
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	1625.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	1366.38	27.69	0.00	5.54
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	1659.27	15.02	2.50	2.50
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	1542.87	23.74	0.00	23.74
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	1222.51	25.63	5.13	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	1659.19	18.28	0.00	13.71
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	1323.83	24.36	1.62	4.87
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	1263.82	18.34	0.00	3.33
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	1521.21	18.15	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	1262.59	19.85	2.65	3.97
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	1354.76	17.74	4.43	5.54
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	1712.92	26.19	15.71	10.48
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	1022.90	20.16	5.67	5.67
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	1337.83	24.75	3.09	9.28
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	1609.82	0.00	0.00	14.63
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	1064.02	16.15	0.65	4.52
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	1257.35	14.49	3.22	4.83
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	2031.19	35.84	0.00	11.95
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	1086.23	8.96	4.89	4.07
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	1079.75	22.67	0.84	1.26
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	1624.08	0.00	14.37	14.37
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	1064.88	20.09	4.82	4.02
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	1289.82	21.24	2.77	5.54
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	1221.54	0.00	0.00	15.08
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	1204.17	26.91	1.42	6.14
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	1198.12	15.42	4.53	5.44
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	1592.19	14.74	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	1186.96	23.67	3.23	5.38
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	1457.22	13.98	0.00	5.08
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	2267.39	32.86	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	1035.59	9.57	3.19	1.91
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	1418.03	14.58	9.11	3.65
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	1833.31	15.80	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	958.27	17.14	2.14	4.28
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	1287.51	19.91	6.64	6.64
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	1376.01	20.85	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	996.66	19.14	1.85	6.79
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	1325.80	26.34	1.76	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	1436.41	28.29	3.14	6.29
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	1028.48	15.99	2.09	4.17
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	1515.97	15.49	2.21	4.43
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	1582.10	22.69	12.97	6.48
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	1144.85	13.08	1.74	2.62
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	1417.36	13.50	2.25	4.50
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	1209.15	10.45	0.00	3.48
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	1173.45	21.34	4.27	7.47
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	1147.15	19.40	1.39	2.77
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	1330.76	19.95	5.70	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	1110.95	20.25	2.76	7.36
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	1403.75	21.18	6.05	6.05
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	1322.45	6.21	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	1257.21	10.57	3.17	5.29
Keratinocyte - epidermal, donor1	11272-116H3	382.54	16.32	0.73	1.31
Keratinocyte - epidermal, donor2	11349-117G8	945.80	11.71	0.00	0.59
Keratinocyte - epidermal, donor3	11421-118F8	618.48	10.51	2.65	3.69
Keratinocyte - oral, donor1	11251-116E9	751.49	16.80	2.61	2.84
Keratocytes, donor1	11527-119I6	1312.06	7.22	1.72	0.69
Keratocytes, donor2	11607-120I5	978.45	19.92	2.34	3.52
Keratocytes, donor3	11688-122I5	645.55	2.96	0.20	2.77
Krukenberg tumor cell line:HSKTC	10687-109F3	353.86	6.59	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	802.59	9.71	0.00	1.08
Lens Epithelial Cells, donor2	11609-120I7	429.84	3.92	0.92	1.15
Lens Epithelial Cells, donor3	11690-122I7	416.66	19.07	0.00	0.61
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	429.84	13.99	1.30	2.85
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	407.73	10.60	0.56	2.51
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	409.11	12.44	1.89	3.62
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	675.91	9.68	2.69	3.23
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	331.87	13.87	3.15	1.89
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	441.39	13.26	3.02	3.56
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	530.64	10.26	0.00	0.41
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	551.65	11.38	2.78	3.03
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	393.54	10.98	1.69	2.53
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	495.60	10.28	2.77	1.98
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	440.50	12.60	1.16	1.55
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	507.86	15.74	1.30	2.59
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	589.18	13.24	2.09	2.79
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	440.79	15.98	2.39	1.67
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	425.92	14.70	1.65	2.61
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	541.08	6.47	0.92	2.16
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	501.60	13.09	0.62	3.43
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	464.61	15.74	1.46	2.56
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	614.78	15.80	0.33	3.95
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	508.13	13.47	1.46	2.64
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	486.41	14.44	1.74	4.98
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	577.11	12.61	2.42	3.39
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	426.30	11.31	0.81	2.15
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	458.07	12.11	2.42	3.33
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	529.82	10.37	1.04	3.63
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	435.32	11.94	1.47	1.26
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	459.09	12.63	1.65	2.71
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	650.04	9.63	0.69	1.38
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	431.61	14.30	0.56	2.26
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	440.87	15.27	2.33	3.39
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	548.06	11.63	2.91	2.42
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	376.44	11.25	1.32	2.65
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	459.89	12.64	2.11	3.47
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	507.93	12.59	1.48	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	397.56	11.12	1.73	2.72
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	449.88	11.82	2.47	2.75
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	546.78	13.19	0.32	2.57
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	388.02	12.17	1.83	1.83
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	432.36	9.94	1.68	2.52
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	544.01	11.38	2.13	1.78
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	441.15	11.63	2.91	2.42
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	484.72	14.16	1.56	2.80
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	637.07	17.19	2.51	3.58
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	426.31	9.80	1.63	1.63
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	498.16	12.24	2.35	2.59
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	389.69	11.76	0.87	2.10
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	461.29	12.29	1.54	1.79
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	666.53	12.53	2.69	2.09
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	1275.76	31.72	2.27	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	1831.15	26.85	2.30	6.14
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	1831.08	30.43	2.23	4.45
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	1267.69	32.58	6.77	9.73
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	1915.15	37.98	4.92	7.74
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	2208.83	30.82	0.93	9.34
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	1311.36	24.22	12.88	14.43
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	1949.52	24.98	3.57	11.89
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	1009.95	40.71	2.49	5.65
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	1231.95	30.83	8.14	10.76
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	1594.97	25.21	6.75	5.85
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	946.37	39.56	2.17	5.42
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	1375.73	34.41	6.16	7.19
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	1501.40	28.93	3.53	4.94
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	1776.37	30.65	3.33	6.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	1306.07	32.09	8.15	6.62
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	1398.33	28.55	5.07	8.80
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	1399.33	29.66	7.56	10.58
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	1412.42	34.36	7.36	14.11
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	1776.81	30.17	7.34	15.49
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	1194.90	30.82	8.12	11.25
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	1306.30	35.03	8.13	14.29
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	1641.33	28.85	6.18	8.24
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	1300.27	36.29	4.64	11.90
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	1211.26	32.58	8.07	11.06
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	1439.02	28.22	3.87	7.19
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	1290.58	30.75	7.07	10.96
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	1276.72	32.82	5.90	13.28
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	1600.27	31.08	10.36	10.36
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	1596.03	38.76	5.37	12.66
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	1156.04	24.91	15.29	12.45
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	1698.37	29.54	3.28	7.38
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	1355.20	36.15	4.97	11.30
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	1367.35	25.85	8.62	13.64
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	1782.11	22.41	2.24	5.98
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	1082.82	32.70	7.06	15.98
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	1217.29	24.12	7.75	14.21
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	1650.09	28.26	3.43	7.71
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	1531.95	30.65	10.33	11.99
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	1434.67	30.17	5.43	9.65
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	1663.02	34.13	4.98	12.80
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	1285.16	27.84	8.25	11.34
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	1243.11	25.23	8.05	12.88
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	1729.19	29.63	4.71	11.45
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	1326.80	30.00	6.30	14.82
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	1033.84	30.24	6.98	5.81
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	1821.43	30.67	5.29	7.40
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	1366.52	30.81	7.60	10.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	1243.68	29.80	3.63	8.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	1920.89	39.86	9.96	14.56
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	1485.26	38.97	6.91	15.78
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	1086.78	30.11	4.70	9.41
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	1834.29	33.69	3.02	13.07
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	1467.68	31.54	5.86	11.72
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	1168.63	20.65	8.61	13.77
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	1723.48	33.40	9.80	12.47
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	1361.16	34.02	8.60	9.78
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	1187.52	29.03	7.92	13.85
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	1843.74	36.32	5.71	12.97
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	1257.57	28.00	8.75	7.88
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	1259.10	20.13	3.35	6.15
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	1691.93	34.45	7.51	11.92
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	1482.69	33.94	5.79	11.19
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	1250.19	24.81	6.58	12.15
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	1652.37	34.60	5.77	10.57
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	1349.67	32.60	4.77	13.52
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	1417.58	27.95	4.25	17.01
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	1956.83	18.68	8.30	8.99
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	1298.43	35.34	6.46	14.44
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	1348.88	26.85	9.81	19.62
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	2066.71	19.95	6.65	6.65
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	1331.93	35.81	6.02	14.58
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	1356.71	31.45	5.33	8.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	2179.73	17.81	8.62	8.62
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	1414.14	30.85	7.71	8.23
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	1238.58	29.71	2.83	12.73
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	2175.74	16.46	5.11	7.94
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	1402.42	38.27	5.82	9.98
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	1164.38	31.32	7.83	14.88
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	2155.38	16.70	5.01	7.10
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	1632.27	47.39	6.97	11.15
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	1414.37	25.42	8.70	12.71
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	2458.82	20.32	7.48	10.16
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	1454.74	33.94	8.08	14.95
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	1395.00	29.37	4.59	11.01
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	2198.77	16.00	7.11	11.56
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	1737.53	28.49	7.98	9.12
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	1465.54	26.84	2.30	10.74
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	2179.40	18.06	3.83	8.75
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	1568.42	34.30	5.79	10.25
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	1061.92	50.17	3.64	4.94
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	2493.28	27.19	5.30	11.27
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	1608.84	27.02	2.08	20.79
Macrophage - monocyte derived, donor1	11232-116C8	158.63	2.73	0.46	0.91
Macrophage - monocyte derived, donor2	11313-117C8	160.39	5.87	0.18	0.73
Macrophage - monocyte derived, donor3	11389-118C3	239.35	5.11	0.66	1.18
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	549.61	45.14	0.53	1.59
Mallassez-derived cells, donor2	11929-125I3	454.92	11.41	0.16	1.58
Mallassez-derived cells, donor3	11930-125I4	663.80	16.54	0.28	1.67
Mammary Epithelial Cell, donor1	11273-116H4	560.59	20.63	0.70	0.80
Mammary Epithelial Cell, donor2	11350-117G9	788.73	19.40	0.87	1.74
Mammary Epithelial Cell, donor3	11422-118F9	865.76	32.92	0.50	2.99
Mast cell - stimulated, donor1	11487-119E2	224.40	1.36	1.36	0.00
Mast cell, donor1	11563-120D6	259.86	1.84	0.54	0.00
Mast cell, donor2	11565-120D8	459.13	0.30	1.49	0.59
Mast cell, donor3	11566-120D9	518.24	0.68	0.90	0.68
Mast cell, donor4	11567-120E1	454.75	0.53	1.06	1.42
Mast cell, expanded and stimulated, donor5	11940-126A5	406.87	2.66	0.44	0.78
Mast cell, expanded and stimulated, donor8	11942-126A7	401.57	5.25	0.00	2.33
Mast cell, expanded, donor5	11939-126A4	370.55	1.61	0.57	1.03
Mast cell, expanded, donor8	11941-126A6	466.95	2.18	1.51	1.51
Melanocyte - dark, donor1	11502-119F8	522.96	28.46	0.60	1.49
Melanocyte - dark, donor2	11582-120F7	728.85	8.31	2.08	2.77
Melanocyte - dark, donor3	11663-122F7	341.56	13.18	0.36	0.43
Melanocyte - light, donor1	11274-116H5	367.42	8.46	0.71	0.24
Melanocyte - light, donor2	11351-117H1	563.03	6.82	0.00	2.05
Melanocyte - light, donor3	11423-118G1	403.26	7.81	0.87	1.73
Melanocyte, donor1 (MC+1)	12641-134G4	509.69	7.50	1.98	2.50
Melanocyte, donor2 (MC+2)	12739-135I3	377.59	11.83	2.15	1.88
Melanocyte, donor3 (MC+3)	12837-137B2	421.87	3.75	0.27	0.00
Meningeal Cells, donor1	11493-119E8	823.26	10.55	0.25	1.24
Meningeal Cells, donor2	11573-120E7	1014.98	11.00	1.76	0.44
Meningeal Cells, donor3	11654-122E7	441.01	26.00	0.73	1.79
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	639.03	17.68	1.14	0.86
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	307.53	9.06	0.30	1.11
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	2617.82	11.83	1.31	1.31
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	1657.44	37.94	1.31	5.23
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	769.99	38.03	2.15	2.15
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	448.31	4.66	0.85	1.06
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	587.09	5.53	0.50	1.01
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	877.47	24.83	1.32	0.44
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	1066.66	21.92	1.46	3.65
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	1042.66	21.07	1.43	3.68
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	880.91	4.43	0.55	1.80
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	854.59	9.29	1.86	1.49
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	404.06	3.68	1.05	1.84
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	1203.28	13.35	1.19	1.78
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	1011.29	7.01	7.01	9.34
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	1105.97	31.38	1.92	3.20
Mesenchymal stem cells - adipose, donor0	11217-116B2	607.52	34.74	1.06	2.48
Mesenchymal stem cells - hepatic, donor0	11218-116B3	551.33	3.75	0.31	1.56
Mesenchymal stem cells - umbilical, donor0	11214-116A8	1283.75	33.38	2.90	2.90
Mesothelial Cells, donor1	11247-116E5	271.01	9.55	0.80	0.53
Mesothelial Cells, donor2	12156-128G5	326.30	7.51	0.00	1.50
Mesothelial Cells, donor3	11402-118D7	279.88	12.86	0.87	1.23
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	67.52	4.05	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	241.60	3.45	0.00	0.49
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	206.71	7.36	0.88	0.59
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	65.68	10.37	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	228.12	2.79	0.62	2.79
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	175.28	8.09	0.21	0.83
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	69.48	4.63	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	226.49	2.00	0.25	1.50
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	166.64	2.79	0.00	0.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	97.33	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	196.31	2.24	1.02	0.20
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	160.36	8.32	0.40	0.79
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	111.17	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	305.30	0.88	0.88	4.42
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	196.81	2.28	0.38	0.76
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	85.53	2.63	0.00	1.32
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	209.68	3.61	0.21	1.49
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	104.97	2.76	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	169.00	1.79	0.89	0.30
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	93.89	1.68	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	101.85	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	192.44	2.01	0.75	1.25
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	147.12	5.23	0.48	0.71
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	77.40	2.76	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	211.37	5.07	0.00	1.15
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	130.83	3.79	0.21	0.42
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	154.71	2.65	0.41	0.82
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	209.39	3.86	0.21	0.43
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	140.93	5.33	0.00	0.89
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	92.87	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	188.35	2.63	0.44	0.66
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	111.53	2.03	0.00	1.01
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	64.62	3.31	1.66	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	155.74	2.99	0.82	0.54
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	129.98	3.53	0.00	0.59
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	73.05	4.36	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	267.19	3.84	0.48	2.40
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	126.87	3.20	0.80	2.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	102.84	2.74	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	257.80	2.50	1.00	1.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	80.84	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	114.16	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	215.46	3.07	0.00	0.88
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	142.37	1.10	1.10	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	96.70	3.20	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	202.80	4.46	0.00	0.99
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	157.27	2.78	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	81.77	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	181.54	2.74	0.34	1.03
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	146.60	2.63	0.00	0.88
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	102.62	1.07	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	171.70	3.09	0.00	0.84
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	139.65	4.57	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	92.66	4.66	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	127.00	0.60	0.60	0.60
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	178.64	2.09	0.00	0.83
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	129.94	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	141.30	0.00	1.85	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	181.55	7.40	0.57	1.14
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	98.80	1.66	0.00	0.14
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	132.68	3.11	0.78	0.26
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	183.60	2.14	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	77.49	1.27	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	94.21	0.80	0.80	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	191.87	3.29	0.00	0.30
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	97.18	0.71	0.14	0.42
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	155.75	2.55	0.32	0.96
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	178.67	2.65	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	80.77	1.90	0.00	0.38
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	136.94	1.42	0.57	1.14
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	191.97	3.44	0.74	0.49
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	83.41	1.96	0.00	0.65
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	120.55	2.35	0.00	0.29
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	198.08	3.17	0.58	0.86
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	79.13	0.82	0.00	0.41
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	121.50	2.08	0.00	0.30
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	485.93	11.30	3.77	11.30
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	493.68	1.78	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	323.31	2.96	0.66	2.30
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	532.29	5.26	1.05	1.05
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	245.53	1.78	0.20	0.79
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	434.00	1.86	0.93	1.86
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	389.80	2.63	0.38	2.25
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	357.96	4.00	0.53	1.33
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	178.47	1.58	0.57	0.34
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	331.53	2.95	0.74	2.95
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	295.70	1.10	0.00	1.10
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	353.12	1.56	0.00	3.11
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	284.32	4.81	0.00	2.14
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	479.12	0.00	11.59	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	409.03	0.00	1.01	1.01
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	354.60	4.64	0.42	0.42
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	302.35	2.72	1.36	1.36
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	513.09	3.81	0.00	1.27
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	486.71	3.24	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	326.25	6.04	1.51	4.53
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	365.45	22.84	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	391.49	22.84	0.00	3.26
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	185.35	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	539.61	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	462.76	8.62	0.86	1.29
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	647.52	2.61	0.00	2.09
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	456.56	12.01	1.33	0.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	471.21	5.01	0.42	0.42
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	499.50	6.08	1.52	1.14
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	901.66	4.79	1.60	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	358.33	5.44	0.68	1.36
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	200.30	1.84	0.00	1.84
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	526.10	10.04	0.00	0.84
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	546.93	6.74	0.93	0.93
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	523.97	4.05	0.54	1.35
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	481.65	1.47	0.00	1.05
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	167.02	0.00	11.13	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	555.92	5.46	0.99	0.99
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	451.21	5.41	1.62	1.62
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	472.40	4.08	1.36	1.81
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	442.55	3.10	1.31	0.65
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	387.66	0.73	1.09	1.09
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	488.00	1.59	0.00	2.12
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	477.24	5.40	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	335.07	1.64	2.30	3.28
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	432.09	2.28	0.65	0.98
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	351.53	1.06	0.71	0.88
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	580.17	1.41	0.70	3.52
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	643.59	4.14	0.92	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	610.88	5.78	1.93	2.57
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	413.52	2.41	1.72	4.14
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	242.73	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	351.55	1.56	0.00	0.22
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	548.72	3.39	1.27	1.69
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	497.01	4.98	0.95	2.37
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	743.03	10.73	1.29	1.29
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	162.50	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	644.45	2.33	1.67	1.67
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	339.50	1.80	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	432.51	6.35	0.79	2.38
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	678.84	5.57	5.57	2.79
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	704.91	3.78	2.27	4.16
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	572.58	3.58	1.96	1.96
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	593.10	2.18	0.44	1.31
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	387.61	2.26	0.90	0.45
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	486.81	2.65	3.53	2.65
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	709.39	5.32	1.99	1.99
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	617.57	2.98	0.50	2.48
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	450.97	2.30	0.00	1.15
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	709.84	0.60	1.81	2.72
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	375.52	2.21	0.44	0.88
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	573.97	1.36	1.36	2.71
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	255.48	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	696.26	3.66	0.61	3.05
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	442.52	2.52	0.31	0.31
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	590.17	2.12	0.61	2.42
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	467.56	0.79	0.79	0.79
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	383.17	4.53	4.53	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	242.78	5.06	10.12	5.06
Myoblast, donor1	11241-116D8	331.44	17.89	1.61	2.24
Myoblast, donor2	11322-117D8	477.17	17.45	2.49	3.26
Myoblast, donor3	11398-118D3	272.42	8.24	0.67	0.67
NK T cell leukemia cell line:KHYG-1	10777-110G3	865.67	6.13	0.88	2.04
Natural Killer Cells, donor1	11230-116C6	448.05	1.85	0.00	0.62
Natural Killer Cells, donor2	11311-117C6	504.81	1.81	3.32	4.22
Natural Killer Cells, donor3	11387-118C1	628.73	1.84	0.74	2.21
Neural stem cells, donor1	11275-116H6	297.97	7.98	0.73	0.73
Neural stem cells, donor2	11352-117H2	375.50	3.85	0.00	0.00
Neurons, donor1	11494-119E9	790.84	7.97	1.14	4.55
Neurons, donor2	11574-120E8	372.52	6.38	1.32	1.10
Neurons, donor3	11655-122E8	628.13	9.04	4.93	4.93
Neutrophils, donor1	11233-116C9	38.98	0.93	0.00	0.00
Neutrophils, donor2	11314-117C9	34.79	0.00	0.00	2.90
Neutrophils, donor3	11390-118C4	50.70	1.22	0.61	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	445.73	5.34	0.83	2.49
Nucleus Pulposus Cell, donor2	11409-118E5	442.17	12.05	1.63	3.58
Nucleus Pulposus Cell, donor3	11462-119B4	1012.39	4.21	2.61	4.01
Olfactory epithelial cells, donor1	11933-125I7	354.45	6.74	1.10	1.93
Olfactory epithelial cells, donor2	11934-125I8	415.85	6.80	3.62	5.50
Olfactory epithelial cells, donor3	11935-125I9	349.48	2.72	0.57	1.70
Olfactory epithelial cells, donor4	11936-126A1	408.09	4.58	0.58	1.75
Oligodendrocyte - precursors, donor1	11496-119F2	547.05	15.05	0.00	1.81
Osteoblast - differentiated, donor1	11276-116H7	703.17	8.08	0.21	1.49
Osteoblast - differentiated, donor2	11353-117H3	604.71	6.86	11.43	6.86
Osteoblast - differentiated, donor3	11425-118G3	1006.17	15.52	1.86	6.21
Osteoblast, donor1	11277-116H8	1079.99	49.25	2.54	3.32
Osteoblast, donor2	11354-117H4	642.62	11.94	0.70	0.00
Osteoblast, donor3	11426-118G4	878.88	20.79	1.60	3.20
Pancreatic stromal cells, donor1	11249-116E7	451.17	7.41	1.52	2.36
Pericytes, donor1	11491-119E6	1105.32	3.23	0.78	1.78
Pericytes, donor2	11571-120E5	1376.76	3.85	1.81	3.40
Pericytes, donor3	11652-122E5	949.30	11.60	3.05	4.27
Perineurial Cells, donor1	11499-119F5	468.13	9.61	0.57	1.24
Perineurial Cells, donor2	11579-120F4	375.50	8.93	0.18	0.83
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	493.09	1.27	0.32	0.96
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	459.36	1.71	3.92	3.43
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	537.08	1.42	0.78	1.94
Placental Epithelial Cells, donor1	11278-116H9	871.52	21.05	1.67	1.91
Placental Epithelial Cells, donor2	11355-117H5	1148.80	16.63	0.00	1.11
Placental Epithelial Cells, donor3	11427-118G5	881.90	14.53	2.16	3.53
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	603.16	6.96	2.53	5.70
Preadipocyte - breast, donor1	11467-119B9	233.55	8.07	0.19	0.56
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	151.02	1.17	0.13	0.65
Preadipocyte - breast, donor2	11328-117E5	470.79	9.23	2.03	4.50
Preadipocyte - omental, donor1	11468-119C1	265.22	6.82	1.07	1.07
Preadipocyte - omental, donor2	11329-117E6	214.31	3.93	0.00	1.75
Preadipocyte - omental, donor3	11403-118D8	344.08	14.75	1.00	0.86
Preadipocyte - perirenal, donor1	11469-119C2	882.89	7.87	1.97	0.98
Preadipocyte - subcutaneous, donor1	11279-116I1	499.37	14.43	0.61	0.31
Preadipocyte - subcutaneous, donor2	11356-117H6	510.87	15.58	3.01	4.60
Preadipocyte - subcutaneous, donor3	11428-118G6	670.92	20.95	2.21	3.41
Preadipocyte - visceral, donor1	11280-116I2	363.09	10.15	0.00	0.75
Preadipocyte - visceral, donor2	11357-117H7	235.61	4.14	1.38	1.84
Preadipocyte - visceral, donor3	11429-118G7	677.94	6.27	3.66	4.49
Prostate Epithelial Cells (polarized), donor1	11253-116F2	432.04	9.50	2.56	1.81
Prostate Epithelial Cells, donor2	11331-117E8	398.25	19.09	3.52	3.52
Prostate Epithelial Cells, donor3	11404-118D9	764.06	9.68	2.57	3.74
Prostate Stromal Cells, donor1	11254-116F3	462.09	15.38	1.03	2.62
Prostate Stromal Cells, donor2	11332-117E9	575.73	10.22	3.05	6.28
Prostate Stromal Cells, donor3	11405-118E1	515.23	6.57	2.82	3.55
Renal Cortical Epithelial Cells, donor1	11516-119H4	984.36	8.03	0.73	1.82
Renal Cortical Epithelial Cells, donor2	11596-120H3	346.00	9.01	0.62	0.97
Renal Epithelial Cells, donor1	11517-119H5	1628.72	53.26	2.03	1.52
Renal Epithelial Cells, donor2	11597-120H4	1173.68	34.85	0.71	1.42
Renal Epithelial Cells, donor3	11678-122H4	352.00	16.73	0.74	1.59
Renal Glomerular Endothelial Cells, donor1	11514-119H2	993.36	7.49	1.36	1.36
Renal Glomerular Endothelial Cells, donor2	11594-120H1	972.86	11.86	2.56	2.29
Renal Glomerular Endothelial Cells, donor3	11675-122H1	616.97	12.65	0.89	2.66
Renal Glomerular Endothelial Cells, donor4	11783-124B1	1167.19	28.61	0.67	2.66
Renal Mesangial Cells, donor1	11518-119H6	829.07	13.65	0.88	1.76
Renal Mesangial Cells, donor2	11598-120H5	1123.56	16.30	1.25	3.76
Renal Mesangial Cells, donor3	11679-122H5	962.06	11.10	2.22	1.66
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	791.31	20.40	0.27	0.54
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	1061.40	15.60	1.27	3.37
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	607.28	28.93	1.74	3.09
Retinal Pigment Epithelial Cells, donor0	11215-116A9	670.24	22.30	1.56	2.59
Retinal Pigment Epithelial Cells, donor1	11528-119I7	951.37	13.93	1.14	1.71
Retinal Pigment Epithelial Cells, donor2	11608-120I6	1305.96	17.50	1.03	2.06
Retinal Pigment Epithelial Cells, donor3	11689-122I6	399.70	8.53	0.00	2.01
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	309.10	3.34	0.53	0.67
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	1070.30	5.36	1.79	1.79
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	929.58	4.95	1.65	3.85
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	789.45	2.90	0.00	2.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	865.06	4.03	1.30	1.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	778.55	13.11	2.48	4.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	559.03	14.72	0.89	1.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	980.81	9.30	1.36	2.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	825.14	13.87	2.33	4.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	745.63	11.33	3.47	6.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	1234.37	4.52	1.37	2.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	749.86	11.65	3.93	7.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	595.63	16.66	0.90	1.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	1331.71	4.45	1.15	2.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	721.37	13.09	3.86	4.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	883.53	13.05	2.66	2.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	1268.26	4.59	2.10	1.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	663.97	12.86	2.42	3.63
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	437.64	10.52	0.75	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	1102.79	4.91	1.33	2.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	682.36	9.54	1.95	2.92
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	711.70	11.46	1.53	1.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	1132.76	5.13	1.39	2.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	653.67	11.21	4.48	6.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	636.43	9.91	1.71	2.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	1145.58	4.01	0.91	2.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	705.14	12.14	1.23	2.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	853.87	12.63	2.82	3.63
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	1499.91	5.66	0.94	4.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	680.36	13.69	3.57	4.76
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	899.84	16.14	2.34	6.31
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	1504.36	7.26	1.24	2.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	587.09	12.39	6.42	10.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	712.50	13.16	1.25	3.97
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	1392.95	5.65	2.02	2.02
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	623.96	12.94	1.02	2.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	695.02	12.92	1.74	0.77
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	1436.19	5.50	1.89	3.78
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	638.66	13.72	1.92	2.06
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	660.45	12.81	4.76	4.93
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	1186.88	4.26	1.19	4.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	702.21	13.32	1.78	3.26
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	693.83	10.13	0.53	0.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	1437.56	3.18	0.69	3.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	831.21	10.00	4.76	3.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	732.00	8.06	0.81	0.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	1540.22	4.14	1.51	3.67
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	972.28	9.78	2.79	5.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	719.27	7.56	0.91	1.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	1550.88	4.90	2.33	3.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	376.11	5.68	1.02	0.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	1078.13	6.08	4.26	6.08
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	1682.11	4.82	1.51	2.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	686.93	6.56	3.62	3.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	746.45	9.59	2.10	4.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	1008.12	3.78	2.60	2.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	842.04	11.74	10.25	6.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	694.13	3.61	2.40	3.00
Schwann Cells, donor1	11498-119F4	1809.62	12.60	3.76	5.83
Schwann Cells, donor2	11578-120F3	871.02	3.40	0.00	3.40
Schwann Cells, donor3	11659-122F3	746.19	18.18	2.19	3.29
Sebocyte, donor1	11220-116B5	674.85	19.72	1.10	1.10
Sebocyte, donor2	11301-117B5	571.69	22.52	1.84	3.68
Sebocyte, donor3	11378-118B1	842.59	19.37	1.03	5.36
Sertoli Cells, donor1	11255-116F4	458.88	14.91	0.00	1.66
Sertoli Cells, donor2	11333-117F1	451.90	11.30	5.65	8.47
Skeletal Muscle Cells, donor1	11281-116I3	825.06	15.48	1.06	1.67
Skeletal Muscle Cells, donor2	11358-117H8	865.24	5.06	2.17	5.78
Skeletal Muscle Cells, donor3	11430-118G8	1526.61	13.38	6.69	4.18
Skeletal Muscle Cells, donor4	11451-119A2	1056.14	10.53	4.08	3.77
Skeletal Muscle Cells, donor5	11455-119A6	1120.33	10.26	4.16	5.20
Skeletal Muscle Cells, donor6	11459-119B1	1317.87	21.85	3.85	6.31
Skeletal Muscle Satellite Cells, donor1	11240-116D7	629.53	15.88	1.89	2.65
Skeletal Muscle Satellite Cells, donor2	11321-117D7	715.30	16.84	2.85	4.57
Skeletal Muscle Satellite Cells, donor3	11397-118D2	615.60	20.83	1.69	4.66
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	531.97	13.06	0.25	0.93
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	1414.23	36.91	1.45	6.51
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	909.53	8.39	3.03	4.95
Skin - palm, donor1	10286-104F7	1122.79	5.37	2.69	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	897.95	28.25	2.16	3.89
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	628.96	3.27	2.45	0.82
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	921.13	25.58	1.82	4.28
Small Airway Epithelial Cells, donor1	11256-116F5	520.31	16.96	1.81	2.22
Small Airway Epithelial Cells, donor2	11334-117F2	530.42	16.88	2.95	3.38
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	280.38	9.52	0.42	0.21
Small Airway Epithelial Cells, donor3	11406-118E2	503.52	14.17	1.80	2.70
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	1909.52	17.28	2.78	6.17
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	384.41	2.67	0.44	0.44
Smooth Muscle Cells - Aortic, donor0	11210-116A4	656.60	35.27	0.00	1.76
Smooth Muscle Cells - Aortic, donor1	11283-116I5	353.59	15.91	0.22	0.88
Smooth Muscle Cells - Aortic, donor2	11360-117I1	584.76	35.83	0.39	1.58
Smooth Muscle Cells - Aortic, donor3	11432-118H1	735.48	34.77	0.77	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	512.39	7.01	3.00	2.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	611.09	37.79	0.53	1.06
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	525.99	9.09	2.88	4.43
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	1287.60	26.76	4.10	4.35
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	384.85	10.42	1.30	0.65
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	392.19	12.70	0.59	0.89
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	478.63	11.39	0.71	2.70
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	1165.08	21.64	0.49	1.46
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	600.65	3.65	0.30	1.52
Smooth Muscle Cells - Carotid, donor1	11285-116I7	658.43	16.67	1.52	1.52
Smooth Muscle Cells - Carotid, donor2	11362-117I3	483.54	6.12	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	1078.13	14.78	0.48	3.34
Smooth Muscle Cells - Colonic, donor1	11239-116D6	346.12	22.42	1.47	1.18
Smooth Muscle Cells - Colonic, donor2	11320-117D6	602.88	7.75	3.44	4.95
Smooth Muscle Cells - Colonic, donor3	11396-118D1	536.13	12.18	2.62	2.83
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	554.21	30.78	0.93	1.39
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	818.11	36.65	7.55	6.47
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	860.11	22.12	2.09	6.28
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	1186.36	25.26	0.68	2.73
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	443.14	6.67	1.26	1.81
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	322.25	18.82	1.21	1.31
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	381.61	13.65	1.82	1.59
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	1315.10	13.89	6.04	9.06
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	502.83	27.02	1.59	1.85
Smooth Muscle Cells - Prostate, donor1	11257-116F6	671.39	1.73	0.67	1.46
Smooth Muscle Cells - Prostate, donor2	11335-117F3	530.43	8.26	3.13	4.26
Smooth Muscle Cells - Prostate, donor3	11465-119B7	386.84	2.03	0.25	0.25
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	530.57	27.14	0.90	1.06
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	721.66	9.00	3.00	2.25
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	687.46	7.75	0.00	2.58
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	554.36	20.00	1.86	3.26
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	524.57	22.72	1.51	4.54
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	674.11	9.40	5.64	3.13
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	599.44	16.22	0.59	1.77
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	392.13	15.08	0.25	0.33
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	499.86	7.94	0.93	2.34
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	513.50	13.96	0.43	1.30
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	808.72	27.03	4.08	5.10
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	1112.59	12.22	2.44	2.82
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	476.39	13.69	0.42	0.84
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	684.47	13.66	0.59	1.01
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	1691.87	10.00	3.33	5.71
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	490.79	15.66	0.98	0.98
Smooth Muscle Cells - Uterine, donor1	11258-116F7	839.16	2.65	1.55	1.33
Smooth Muscle Cells - Uterine, donor3	11466-119B8	628.46	15.80	1.46	5.27
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	642.95	2.14	0.58	1.17
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	519.12	4.50	1.32	2.12
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	531.14	1.86	2.98	4.46
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	712.21	3.59	2.16	2.52
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	617.20	7.95	2.27	0.57
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	843.67	4.33	3.54	2.36
Smooth muscle cells - airway, control, donor1	11966-126D4	639.20	5.33	1.27	5.59
Smooth muscle cells - airway, control, donor2	11967-126D5	746.33	4.39	1.60	0.80
Smooth muscle cells - airway, control, donor3	11968-126D6	951.38	5.43	2.51	3.76
Smooth muscle cells - airway, control, donor4	11969-126D7	1135.82	5.96	1.38	2.75
Synoviocyte, donor1	11291-117A4	299.61	5.89	1.35	1.35
Synoviocyte, donor2	11368-117I9	432.47	6.03	1.51	4.02
Synoviocyte, donor3	11440-118H9	711.78	1.79	1.34	4.92
Trabecular Meshwork Cells, donor1	11532-120A2	1252.45	27.87	0.71	1.79
Trabecular Meshwork Cells, donor2	11612-122A1	1718.43	15.86	1.98	5.95
Trabecular Meshwork Cells, donor3	11693-123A1	1022.51	17.60	2.08	4.63
Tracheal Epithelial Cells, donor1	11292-117A5	610.75	22.15	1.22	2.22
Tracheal Epithelial Cells, donor2	11369-118A1	851.60	47.55	2.32	3.48
Tracheal Epithelial Cells, donor3	11441-118I1	1291.93	16.61	5.73	4.58
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	320.23	3.94	1.23	1.11
Urethra, donor2	10319-105A4	411.84	3.60	0.00	1.80
Urothelial Cells, donor1	11520-119H8	886.25	13.28	0.27	1.06
Urothelial Cells, donor2	11600-120H7	896.06	25.24	1.20	3.61
Urothelial Cells, donor3	11681-122H7	869.37	9.63	2.52	4.58
Urothelial cells, donor0	11216-116B1	445.79	4.68	0.45	1.34
Whole blood (ribopure), donor090309, donation1	12179-129A1	728.73	0.89	0.00	1.78
Whole blood (ribopure), donor090309, donation2	12180-129A2	800.58	2.86	1.43	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	240.27	0.68	0.68	2.05
Whole blood (ribopure), donor090325, donation1	12176-128I7	324.37	2.07	0.00	0.69
Whole blood (ribopure), donor090325, donation2	12177-128I8	320.73	0.00	1.74	3.49
Whole blood (ribopure), donor090612, donation1	12182-129A4	621.62	1.04	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	597.48	0.92	0.92	3.67
Whole blood (ribopure), donor090612, donation3	12184-129A6	289.39	0.00	3.65	1.83
Wilms' tumor cell line:G-401	10809-111A8	956.30	39.85	1.36	2.71
Wilms' tumor cell line:HFWT	10597-108E3	1033.17	14.08	0.88	2.64
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	1885.95	43.01	3.35	6.70
achilles tendon, donor2	10292-104G4	603.43	0.00	2.07	2.07
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	888.52	37.22	0.76	2.29
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	1041.54	27.40	0.23	1.63
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	772.55	3.92	0.59	1.31
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	527.90	23.95	1.36	1.36
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	2166.59	55.09	4.22	9.56
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	662.78	14.38	1.27	4.02
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	1084.22	6.81	1.09	1.91
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	3659.06	38.78	6.61	19.39
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	873.48	5.31	2.45	5.31
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	2181.46	33.01	1.94	6.21
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	576.66	10.12	1.47	2.39
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	1411.99	3.90	11.70	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	2084.70	19.98	4.18	9.53
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	2279.11	36.51	3.88	6.99
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	1686.54	26.89	4.09	7.60
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	1628.05	18.13	1.39	1.86
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	974.26	6.99	2.06	6.17
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	1903.09	32.54	0.61	2.46
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	1141.45	34.99	1.28	2.99
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	964.17	24.26	0.30	2.12
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	999.65	25.03	0.72	1.20
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	1365.39	26.51	3.56	5.57
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	1081.69	17.68	2.00	2.67
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	1882.36	37.16	0.00	3.72
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	1543.18	39.55	1.88	4.90
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	722.67	11.34	0.87	1.74
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	1373.98	28.12	3.75	1.87
adenocarcinoma cell line:IM95m	10796-110I4	1553.12	39.09	0.94	3.30
adipose tissue, adult, pool1	10010-101C1	216.55	1.40	1.09	0.62
adipose, donor1	10184-103D4	1029.73	2.93	21.70	8.80
adipose, donor2	10185-103D5	1205.20	2.84	2.43	2.03
adipose, donor3	10186-103D6	943.21	11.16	3.27	4.36
adipose, donor4	10187-103D7	911.82	28.60	2.60	3.47
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	347.68	38.67	0.79	1.89
adrenal gland, adult, pool1	10081-102A9	447.43	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	466.52	6.27	0.53	0.93
alveolar cell carcinoma cell line:SW 1573	10708-109H6	1403.47	33.59	4.29	3.22
amniotic membrane cells, donor1	12235-129G3	411.07	6.03	1.39	2.32
amniotic membrane cells, donor2	12236-129G4	519.66	6.42	0.34	1.69
amniotic membrane cells, donor3	12237-129G5	826.36	2.65	1.18	2.95
amygdala - adult, donor10196	10167-103B5	277.48	2.37	0.00	0.00
amygdala, adult, donor10252	10151-102I7	156.33	3.85	0.20	0.61
amygdala, newborn, donor10223	10360-105E9	310.50	5.16	0.00	0.32
anaplastic carcinoma cell line:8305C	10428-106D5	420.06	2.04	1.15	0.25
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	2709.03	99.50	3.53	6.62
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	1165.46	15.70	1.00	3.01
aorta, adult, pool1	10052-101G7	500.73	1.77	0.78	2.55
appendix, adult	10189-103D9	454.10	3.88	5.05	1.55
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	954.08	31.64	1.38	1.72
artery, adult	10190-103E1	679.34	13.59	0.00	5.43
astrocytoma cell line:TM-31	10425-106D2	340.73	7.39	0.58	0.43
b cell line:RPMI1788	10427-106D4	635.55	4.91	0.89	0.74
basal cell carcinoma cell line:TE 354.T	10702-109G9	343.76	6.38	0.28	1.39
bile duct carcinoma cell line:HuCCT1	10432-106D9	764.28	20.94	0.99	0.99
bile duct carcinoma cell line:TFK-1	10496-107C1	399.20	9.04	0.84	1.34
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	1778.94	5.59	1.68	5.03
bladder, adult, pool1	10011-101C2	389.91	4.02	1.52	1.30
blood, adult, pool1	10053-101G8	675.46	2.21	4.43	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	245.77	4.28	0.00	0.86
bone marrow, adult	10192-103E3	322.57	6.75	0.00	8.10
brain, adult, donor1	10084-102B3	351.60	9.23	1.03	2.05
brain, adult, pool1	10012-101C3	177.28	6.46	0.56	0.67
brain, fetal, pool1	10085-102B4	814.78	2.67	0.00	2.67
breast carcinoma cell line:MCF7	10482-107A5	752.57	28.74	5.95	5.29
breast carcinoma cell line:MDA-MB-453	10419-106C5	452.86	6.74	0.37	1.00
breast, adult, donor1	10080-102A8	570.75	1.89	0.00	1.26
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	1341.01	19.94	1.52	3.30
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	1466.94	21.65	3.71	7.73
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	663.72	10.59	2.30	4.83
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	1131.51	30.50	2.18	2.18
carcinoid cell line:NCI-H1770	10703-109H1	968.08	4.23	0.94	1.88
carcinoid cell line:NCI-H727	10735-110B6	616.58	12.69	0.77	1.53
carcinoid cell line:SK-PN-DW	10719-109I8	2337.11	33.27	5.70	6.97
carcinosarcoma cell line:JHUCS-1	10642-109A3	1385.99	9.05	5.32	5.06
caudate nucleus - adult, donor10196	10177-103C6	277.47	0.00	0.00	1.15
caudate nucleus, adult, donor10252	10164-103B2	156.78	3.68	0.33	0.84
caudate nucleus, adult, donor10258	10379-105H1	279.67	0.00	0.00	0.76
caudate nucleus, newborn, donor10223	10354-105E3	319.36	5.86	1.83	1.83
cerebellum - adult, donor10196	10173-103C2	413.68	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	131.95	5.34	0.43	1.49
cerebellum, adult, pool1	10083-102B2	350.12	8.62	1.72	1.03
cerebellum, newborn, donor10223	10357-105E6	323.81	5.81	1.66	0.00
cerebral meninges, adult	10188-103D8	243.31	8.07	1.01	1.76
cerebrospinal fluid, donor2	10294-104G6	551.82	6.58	1.46	2.92
cervical cancer cell line:D98-AH2	10552-107I3	713.59	23.44	0.43	0.72
cervical cancer cell line:ME-180	10553-107I4	459.03	9.11	0.66	1.16
cervix, adult, pool1	10013-101C4	398.86	2.94	0.31	2.10
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	410.91	5.29	1.11	0.56
chondrosarcoma cell line:SW 1353	10700-109G7	492.46	5.23	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	552.28	13.30	1.99	1.86
choriocarcinoma cell line:SCH	10785-110H2	1226.58	17.25	1.48	3.82
choriocarcinoma cell line:T3M-3	10618-108G6	701.34	9.72	1.42	1.90
chorionic membrane cells, donor1	12238-129G6	424.81	5.98	1.42	2.56
chorionic membrane cells, donor2	12239-129G7	401.80	9.25	1.09	1.09
chorionic membrane cells, donor3	12240-129G8	740.16	7.69	6.59	7.69
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	1122.90	16.16	2.02	13.13
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	2457.71	62.43	4.42	5.57
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	2142.06	60.19	1.27	4.86
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	1001.52	19.26	0.51	2.82
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	1038.14	19.83	0.73	3.14
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	944.34	17.10	1.02	1.22
chronic myelogenous leukemia cell line:K562	10454-106G4	915.17	27.38	0.59	1.47
chronic myelogenous leukemia cell line:KU812	10409-106B4	1163.43	34.40	0.78	1.30
clear cell carcinoma cell line:JHOC-5	10638-108I8	1094.22	18.06	8.23	7.31
clear cell carcinoma cell line:TEN	10636-108I6	908.83	13.53	2.08	3.99
colon carcinoma cell line:CACO-2	10513-107D9	513.43	19.22	0.37	2.01
colon carcinoma cell line:COLO-320	10420-106C6	1334.85	14.82	1.52	1.14
colon, adult, donor1	10082-102B1	977.02	7.14	4.76	2.38
colon, adult, pool1	10014-101C5	500.68	4.58	0.94	1.53
colon, fetal, donor1	10070-101I7	831.81	3.09	0.62	2.47
common myeloid progenitor CMP, donor1	12130-128D6	673.78	45.84	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	1952.86	25.04	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	523.94	12.75	0.85	2.12
cord blood derived cell line:COBL-a 24h infection	10453-106G3	566.29	21.13	1.81	1.36
cord blood derived cell line:COBL-a untreated	10449-106F8	631.59	19.88	0.56	1.55
corpus callosum, adult, pool1	10042-101F6	238.37	1.99	0.11	0.88
cruciate ligament, donor2	10295-104G7	469.26	3.24	0.81	3.24
diaphragm, fetal, donor1	10069-101I6	731.13	10.43	0.80	3.21
diencephalon, adult	10193-103E4	190.79	6.96	0.24	0.96
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	1671.57	26.18	12.40	13.78
ductal cell carcinoma cell line:KLM-1	10438-106E6	648.02	15.13	0.77	1.28
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	679.08	9.63	1.69	2.65
ductus deferens, adult	10196-103E7	353.32	4.98	1.00	3.49
duodenum, fetal, donor1, tech_rep1	10071-101I8	1031.21	5.76	2.88	1.44
duodenum, fetal, donor1, tech_rep2	10071-101I8	958.55	6.62	7.36	7.36
dura mater, adult, donor1	10041-101F5	353.06	3.80	0.66	1.16
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	656.45	41.97	1.11	2.00
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	691.53	28.95	1.00	1.72
embryonic pancreas cell line:1B2C6	10604-108F1	1713.57	27.13	1.23	1.85
embryonic pancreas cell line:1C3D3	10605-108F2	1598.61	28.76	2.72	7.27
embryonic pancreas cell line:1C3IKEI	10606-108F3	1601.18	29.02	1.54	2.78
embryonic pancreas cell line:2C6	10603-108E9	2138.32	19.70	3.94	3.94
endometrial carcinoma cell line:OMC-2	10497-107C2	680.78	28.49	1.68	3.35
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	550.77	9.97	1.09	1.09
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	854.24	26.05	3.86	7.40
epidermoid carcinoma cell line:A431	10426-106D3	622.82	11.23	1.11	1.78
epidermoid carcinoma cell line:Ca Ski	10431-106D8	1070.93	51.58	0.33	1.21
epididymis, adult	10197-103E8	389.74	6.28	2.09	2.30
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	536.67	14.55	0.71	0.18
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	995.69	19.66	2.75	1.97
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	606.89	18.48	2.88	5.77
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	563.45	13.48	2.17	3.15
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	661.98	20.73	3.47	4.71
esophagus, adult, pool1	10015-101C6	450.94	4.25	2.12	2.02
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	633.57	10.02	0.88	1.38
eye - muscle inferior rectus, donor1	10272-104E2	719.54	14.49	0.00	4.83
eye - muscle lateral, donor2	10298-104H1	584.97	16.83	0.00	0.00
eye - muscle medial, donor2	10299-104H2	834.89	23.81	0.00	1.49
eye - muscle superior, donor2	10297-104G9	682.17	14.90	0.00	1.15
eye - vitreous humor, donor1	10268-104D7	715.58	4.37	1.46	1.46
eye, fetal, donor1	10054-101G9	485.84	4.32	1.27	1.53
fibrosarcoma cell line:HT-1080	10758-110E2	712.41	22.57	1.54	1.92
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	1486.01	38.22	1.66	3.32
frontal lobe, adult, pool1	10040-101F4	156.69	5.82	0.09	0.47
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	431.76	13.21	0.30	1.80
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	490.65	10.15	0.37	0.46
gall bladder, adult	10198-103E9	446.41	6.28	2.66	1.69
gamma delta positive T cells, donor1	11937-126A2	1100.01	1.07	2.68	2.15
gamma delta positive T cells, donor2	11938-126A3	849.69	3.73	0.75	1.49
gastric adenocarcinoma cell line:MKN1	10614-108G2	1467.11	31.68	8.45	12.88
gastric adenocarcinoma cell line:MKN45	10612-108F9	2295.07	11.80	2.71	5.22
gastric cancer cell line:AZ521	10549-107H9	578.43	16.56	0.98	0.98
gastric cancer cell line:GSS	10560-108A2	794.42	7.32	0.92	0.92
gastrointestinal carcinoma cell line:ECC12	10615-108G3	744.54	13.48	3.20	4.80
giant cell carcinoma cell line:LU65	10487-107B1	693.84	12.85	1.15	2.07
giant cell carcinoma cell line:Lu99B	10433-106E1	1170.34	8.40	1.54	1.26
glassy cell carcinoma cell line:HOKUG	10688-109F4	483.37	17.96	1.75	2.49
glioblastoma cell line:A172, tech_rep1	10444-106F3	207.94	4.64	0.00	0.42
glioblastoma cell line:A172, tech_rep2	10444-106F3	223.30	4.77	0.14	0.28
glioblastoma cell line:T98G	10485-107A8	677.80	16.78	0.66	1.66
glioma cell line:GI-1	10413-106B8	637.30	11.13	0.00	1.17
globus pallidus - adult, donor10196	10175-103C4	376.12	2.92	0.00	0.00
globus pallidus, adult, donor10252	10161-103A8	193.81	4.15	0.73	0.73
globus pallidus, adult, donor10258	10367-105F7	439.52	2.74	1.37	2.74
globus pallidus, newborn, donor10223	10364-105F4	384.77	11.19	1.60	0.53
granulocyte macrophage progenitor, donor1	12131-128D7	768.40	46.50	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	1322.33	10.93	0.00	10.93
granulocyte macrophage progenitor, donor3	12139-128E6	2001.78	26.13	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	499.51	6.40	1.60	1.28
hIPS +CCl2, biol_rep1	14383-156B9	1949.86	16.07	0.46	2.75
hIPS +CCl2, biol_rep2	14384-156C1	1864.26	18.75	0.91	3.66
hIPS +CCl2, biol_rep3	14385-156C2	2715.49	24.48	1.29	3.86
hIPS, biol_rep1	14380-156B6	2623.05	17.25	2.87	5.75
hIPS, biol_rep2	14381-156B7	2687.92	24.69	2.74	3.43
hIPS, biol_rep3	14382-156B8	653.25	7.72	0.00	1.10
hairy cell leukemia cell line:Mo	10712-109I1	830.14	9.19	0.86	3.74
heart - mitral valve, adult	10205-103F7	256.22	2.69	0.90	1.20
heart - pulmonic valve, adult	10206-103F8	177.28	5.23	0.52	0.78
heart - tricuspid valve, adult	10207-103F9	403.83	14.15	0.83	0.83
heart, adult, diseased post-infarction, donor1	10050-101G5	668.49	23.87	1.63	3.06
heart, adult, diseased, donor1	10051-101G6	441.59	9.79	2.98	2.98
heart, adult, pool1	10016-101C7	392.34	9.66	0.69	0.46
heart, fetal, pool1	10046-101G1	606.74	8.83	0.62	1.23
hepatic mesenchymal tumor cell line:LI90	10778-110G4	593.91	8.33	0.62	0.93
hepatoblastoma cell line:HuH-6	10633-108I3	2900.40	17.84	0.00	1.19
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	431.71	27.40	1.55	2.76
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	435.00	33.38	2.79	3.40
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	400.98	30.72	1.92	2.22
hepatoma cell line:Li-7	10484-107A7	581.77	11.34	0.56	0.89
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	1319.47	47.24	0.80	1.21
hippocampus - adult, donor10196	10169-103B7	262.13	1.89	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	153.69	2.04	0.00	0.82
hippocampus, adult, donor10258	10374-105G5	468.57	1.99	0.00	0.50
hippocampus, newborn, donor10223	10363-105F3	277.75	6.70	0.00	0.35
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	2431.00	47.00	28.69	15.87
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	1361.13	55.96	5.89	14.53
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	1730.04	57.13	9.65	9.39
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	1786.32	5.07	9.02	4.51
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	1368.00	6.20	27.89	15.49
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	1640.29	9.87	13.67	7.59
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	1286.35	7.88	10.51	4.67
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	1155.56	6.25	8.83	7.76
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	1280.00	9.18	5.84	1.67
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	882.76	9.47	5.68	2.13
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	993.23	11.41	8.04	6.43
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	917.04	12.79	4.71	2.69
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	1244.83	53.67	7.35	9.23
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	2106.18	56.50	13.76	25.06
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	1750.74	48.87	21.82	14.84
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	1208.66	6.30	8.02	7.45
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	1652.28	5.67	4.36	4.36
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	1796.14	6.50	21.49	5.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	1019.20	3.39	10.74	7.54
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	1621.07	3.18	7.73	7.73
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	1469.70	4.07	4.07	2.51
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	773.23	6.70	5.39	3.10
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	1087.79	7.55	6.39	4.35
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	1138.90	8.67	4.48	3.29
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	1219.31	53.95	8.31	8.87
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	1641.53	44.79	5.71	7.42
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	2064.83	55.94	8.98	12.25
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	1397.06	11.62	7.39	9.86
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	1357.23	10.45	7.29	6.97
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	1334.86	12.10	9.68	3.63
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	1356.93	7.76	5.17	5.17
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	1481.76	7.97	5.31	4.65
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	1143.62	8.98	7.18	5.13
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	949.99	11.50	5.11	8.18
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	1406.16	11.36	4.54	5.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	1021.61	15.46	4.37	2.35
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	1635.72	50.23	5.55	7.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	1851.71	57.04	10.25	8.02
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	1881.48	63.90	6.83	11.71
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	1270.15	9.17	6.72	2.75
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	1164.66	6.51	74.82	26.03
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	1452.17	5.63	17.21	7.61
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	1535.17	6.02	4.93	7.11
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	1376.61	10.86	6.15	4.70
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	1281.85	7.12	7.12	3.56
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	1007.22	2.39	3.58	8.35
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	845.60	9.75	2.17	1.35
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	1005.65	14.28	3.50	2.42
immature langerhans cells, donor1	11904-125F5	711.18	3.63	0.73	1.70
immature langerhans cells, donor2	11905-125F6	547.36	2.38	1.58	1.58
insula, adult, pool1	10039-101F3	177.25	6.15	0.00	0.09
keratoacanthoma cell line:HKA-1	10791-110H8	2088.10	27.31	3.58	4.23
kidney, adult, pool1	10017-101C8	242.61	8.51	0.40	1.80
kidney, fetal, pool1	10045-101F9	502.86	4.03	0.85	1.20
large cell lung carcinoma cell line:IA-LM	10509-107D5	1620.03	94.16	1.99	2.13
large cell lung carcinoma cell line:NCI-H460	10839-111E2	689.41	3.73	2.35	6.64
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	789.78	7.34	0.73	2.75
left atrium, adult, donor1	10079-102A7	488.19	11.99	1.09	2.18
left ventricle, adult, donor1	10078-102A6	471.27	8.60	1.01	1.52
leiomyoblastoma cell line:G-402	10721-110A1	1078.57	28.18	1.37	2.74
leiomyoma cell line:10964C	10569-108B2	433.25	5.39	4.31	7.18
leiomyoma cell line:15242A	10570-108B3	378.26	20.11	1.63	3.80
leiomyoma cell line:15425	10571-108B4	345.77	5.34	1.70	3.89
leiomyosarcoma cell line:Hs 5.T	10722-110A2	387.31	6.35	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	448.54	6.27	0.00	1.05
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	1391.67	88.07	1.65	3.78
liposarcoma cell line:KMLS-1	10782-110G8	652.49	11.40	1.09	3.44
liposarcoma cell line:SW 872	10726-110A6	607.86	9.99	0.61	1.71
liver, adult, pool1	10018-101C9	310.51	7.94	0.65	1.13
liver, fetal, pool1	10086-102B5	486.35	2.82	0.00	0.94
locus coeruleus - adult, donor10196	10182-103D2	143.20	4.08	0.15	0.44
locus coeruleus, adult, donor10252	10165-103B3	160.93	7.01	0.37	0.55
locus coeruleus, adult, donor10258	10375-105G6	315.15	8.18	0.85	1.13
locus coeruleus, newborn, donor10223	10362-105F2	282.24	7.15	0.84	1.26
lung adenocarcinoma cell line:A549	10499-107C4	525.35	6.23	0.83	1.52
lung adenocarcinoma cell line:PC-14	10408-106B3	379.17	12.41	0.00	0.69
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	875.92	32.69	3.03	3.16
lung, adult, pool1	10019-101D1	327.33	2.13	0.71	1.18
lung, fetal, donor1	10068-101I5	834.53	1.43	0.00	0.86
lung, right lower lobe, adult, donor1	10075-102A3	430.27	1.37	2.29	1.37
lymph node, adult, donor1	10077-102A5	862.94	10.89	3.31	1.89
lymphangiectasia cell line:DS-1	10727-110A7	896.00	12.49	1.32	1.97
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	850.62	17.96	2.57	4.38
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	724.62	29.73	2.55	2.55
mature adipocyte, donor1	12231-129F8	301.47	1.33	0.00	0.89
mature adipocyte, donor2	12232-129F9	259.83	2.28	0.21	0.83
mature adipocyte, donor3	12233-129G1	289.93	1.19	0.00	0.47
mature adipocyte, donor4	12234-129G2	309.54	1.84	0.26	0.53
maxillary sinus tumor cell line:HSQ-89	10414-106B9	665.70	17.15	1.19	0.95
medial frontal gyrus - adult, donor10196	10170-103B8	192.89	3.38	2.26	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	123.40	5.52	0.18	0.74
medial frontal gyrus, adult, donor10258	10368-105F8	307.52	5.40	0.00	0.32
medial frontal gyrus, newborn, donor10223	10352-105E1	246.94	4.26	1.71	2.56
medial temporal gyrus - adult, donor10196	10183-103D3	162.51	4.05	0.84	1.69
medial temporal gyrus, adult, donor10252	10156-103A3	137.10	5.31	0.85	0.64
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	404.51	1.93	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	114.83	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	296.48	7.54	0.72	0.72
medulla oblongata - adult, donor10196	10174-103C3	275.82	4.54	0.00	1.30
medulla oblongata, adult, donor10252	10155-103A2	137.93	4.33	0.31	0.62
medulla oblongata, adult, pool1	10038-101F2	163.42	5.31	0.33	0.33
medulla oblongata, newborn, donor10223	10361-105F1	301.70	9.72	0.35	0.35
medulloblastoma cell line:D283 Med	10838-111E1	1373.42	13.95	3.54	5.98
medulloblastoma cell line:ONS-76	10759-110E3	1207.32	44.87	0.86	1.96
melanoma cell line:COLO 679	10514-107E1	350.88	16.39	1.15	0.57
melanoma cell line:G-361	10465-106H6	765.80	22.26	0.27	1.63
meningioma cell line:HKBMM	10691-109F7	1137.71	31.84	6.51	12.66
merkel cell carcinoma cell line:MKL-1	10843-111E6	510.19	5.29	2.64	7.93
merkel cell carcinoma cell line:MS-1	10844-111E7	806.70	9.59	2.59	3.63
mesenchymal precursor cell - adipose, donor1	11747-123G1	682.48	6.60	1.84	3.53
mesenchymal precursor cell - adipose, donor2	11748-123G2	711.13	3.64	3.27	3.27
mesenchymal precursor cell - adipose, donor3	11749-123G3	633.58	9.11	0.83	4.14
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	347.39	3.65	1.26	0.56
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	582.71	4.24	0.96	2.12
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	365.09	0.69	1.39	1.39
mesenchymal precursor cell - cardiac, donor1	11752-123G6	716.57	5.32	1.03	2.75
mesenchymal precursor cell - cardiac, donor2	11753-123G7	623.27	4.60	2.19	3.45
mesenchymal precursor cell - cardiac, donor3	11754-123G8	674.99	10.74	0.66	1.99
mesenchymal precursor cell - cardiac, donor4	11755-123G9	532.06	9.18	2.16	2.43
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	426.22	5.26	1.14	0.71
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	495.35	5.27	0.00	1.65
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	538.13	5.12	1.38	3.18
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	542.47	10.47	1.05	3.14
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	572.27	7.55	0.61	1.43
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	429.91	4.67	1.08	5.03
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	514.97	0.83	0.62	1.03
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	293.88	9.12	0.91	1.14
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	451.44	7.13	0.84	4.20
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	452.80	3.89	0.75	2.39
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	501.55	3.94	1.23	1.93
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	519.84	0.74	1.10	3.68
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	405.20	5.15	0.86	2.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	578.89	14.31	4.63	4.21
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	848.95	8.22	0.46	3.65
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	643.30	10.23	0.77	3.33
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	669.05	9.68	0.52	2.88
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	568.73	8.01	0.62	3.70
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	586.27	8.94	3.29	4.47
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	667.10	11.17	0.68	1.69
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	667.27	9.82	0.39	3.14
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	606.11	12.05	2.32	1.85
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	917.77	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	759.40	12.40	1.73	3.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	629.59	8.03	0.00	0.67
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	624.67	9.37	0.48	2.88
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	529.46	6.60	3.67	1.47
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	617.61	9.40	1.01	1.68
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	624.71	8.19	1.23	4.50
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	651.64	11.60	1.29	3.87
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	1241.42	16.41	5.47	2.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	1141.46	0.00	0.00	10.33
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	926.61	12.02	2.92	6.82
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	1050.50	13.09	0.00	11.64
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	1207.43	10.66	1.60	9.60
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	988.69	10.63	2.45	1.64
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	978.41	13.22	3.50	5.83
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	1045.17	6.30	2.10	6.30
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	991.48	7.95	0.99	11.92
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	1101.23	9.53	4.77	23.84
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	996.18	17.79	2.37	8.89
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	1117.33	10.97	1.22	7.31
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	1893.67	0.00	0.00	27.05
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	1069.15	12.67	2.53	11.40
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	1043.34	7.59	2.76	6.21
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	1113.29	6.45	4.30	6.45
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	1081.78	11.98	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	1274.24	6.89	6.89	10.33
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	1073.28	17.11	0.81	3.67
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	1080.44	23.04	5.56	7.94
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	993.94	11.79	1.18	6.48
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	1023.01	14.65	0.62	3.74
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	1122.81	17.38	4.01	6.68
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	1200.41	13.01	2.37	4.73
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	1150.46	15.41	5.14	2.57
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	1053.93	19.28	2.07	4.82
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	898.57	14.84	2.97	3.46
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	982.44	8.97	0.00	4.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	991.62	8.27	1.91	1.91
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	776.55	8.06	1.61	2.42
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	859.15	6.54	6.54	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	781.78	8.87	5.07	10.14
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	492.79	3.64	1.21	3.03
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	799.86	13.56	0.00	9.04
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	617.76	5.77	1.65	4.94
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	591.31	6.15	1.39	1.19
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	865.75	7.79	0.97	3.24
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	900.47	6.11	3.06	4.07
mesodermal tumor cell line:HIRS-BM	10696-109G3	185.69	2.32	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	957.25	15.59	1.89	2.36
mesothelioma cell line:ACC-MESO-4	10494-107B8	448.75	18.53	0.46	1.39
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	743.61	25.64	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	1042.81	42.33	1.13	4.01
mesothelioma cell line:Mero-25	10850-111F4	1063.73	10.44	1.36	5.45
mesothelioma cell line:Mero-41	10851-111F5	1220.42	8.07	2.20	3.67
mesothelioma cell line:Mero-48a	10852-111F6	1356.93	29.01	2.44	3.76
mesothelioma cell line:Mero-82	10853-111F7	2207.83	26.54	4.99	7.10
mesothelioma cell line:Mero-83	10854-111F8	838.68	28.09	0.68	3.40
mesothelioma cell line:Mero-84	10855-111F9	827.83	15.92	1.01	2.02
mesothelioma cell line:Mero-95	10856-111G1	1013.89	27.12	1.86	2.48
mesothelioma cell line:NCI-H2052	10847-111F1	1522.47	21.87	1.16	5.14
mesothelioma cell line:NCI-H226	10846-111E9	910.39	37.83	2.17	3.44
mesothelioma cell line:NCI-H2452	10848-111F2	709.25	7.52	1.71	2.90
mesothelioma cell line:NCI-H28	10845-111E8	704.87	11.45	2.80	2.54
mesothelioma cell line:No36	10857-111G2	915.00	12.40	1.96	3.26
mesothelioma cell line:ONE58	10858-111G3	337.61	4.34	0.81	4.06
migratory langerhans cells, donor1	11901-125F2	426.07	1.54	1.34	1.92
migratory langerhans cells, donor2	11902-125F3	405.42	1.34	0.98	1.10
migratory langerhans cells, donor3	11903-125F4	596.05	1.79	0.72	1.26
mixed mullerian tumor cell line:HTMMT	10689-109F5	729.35	8.81	9.14	10.12
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	837.36	57.43	2.97	8.05
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	1522.66	20.73	1.84	2.99
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	810.07	12.56	1.33	2.66
myelodysplastic syndrome cell line:SKM-1	10772-110F7	1799.14	18.66	3.51	11.46
myeloma cell line:PCM6	10474-106I6	721.88	13.44	1.78	0.79
myxofibrosarcoma cell line:MFH-ino	10600-108E6	608.24	15.73	2.03	1.01
myxofibrosarcoma cell line:NMFH-1	10684-109E9	743.37	15.10	0.98	0.98
nasal epithelial cells, donor1, tech_rep1	12226-129F3	737.63	9.36	1.00	1.34
nasal epithelial cells, donor1, tech_rep2	12226-129F3	936.54	9.27	1.54	2.87
nasal epithelial cells, donor2	12227-129F4	673.43	6.07	0.00	0.55
neuroblastoma cell line:CHP-134	10508-107D4	1096.24	16.56	0.46	0.92
neuroblastoma cell line:NB-1	10539-107G8	704.56	24.32	0.75	0.19
neuroblastoma cell line:NBsusSR	10607-108F4	1473.48	16.03	2.32	6.96
neuroblastoma cell line:NH-12	10555-107I6	1974.95	12.30	3.17	3.35
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	444.56	0.95	2.14	4.51
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	1367.93	5.23	5.54	8.71
neuroectodermal tumor cell line:TASK1	10774-110F9	1956.24	29.38	2.01	3.22
neuroepithelioma cell line:SK-N-MC	10728-110A8	1848.17	12.08	1.27	2.54
neurofibroma cell line:Hs 53.T	10729-110A9	718.65	22.89	0.80	2.40
neutrophil PMN, donor1	12133-128D9	89.25	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	318.74	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	350.41	18.94	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	852.03	3.89	0.85	1.01
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	858.94	23.21	2.40	1.60
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	518.10	9.30	2.24	2.89
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	336.86	4.47	2.36	2.63
nucleus accumbens, adult, pool1	10037-101F1	179.04	5.06	0.19	0.19
occipital cortex - adult, donor10196	10172-103C1	282.27	6.18	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	153.24	4.83	0.27	0.54
occipital cortex, newborn, donor10223	10355-105E4	263.13	5.82	0.36	0.73
occipital lobe, adult, donor1	10076-102A4	422.99	10.23	1.57	0.52
occipital lobe, fetal, donor1	10073-102A1	756.07	4.29	2.15	3.00
occipital pole, adult, pool1	10036-101E9	196.24	7.41	0.24	0.24
olfactory region, adult	10195-103E6	190.29	3.25	0.57	0.76
optic nerve, donor1	10277-104E7	496.26	2.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	613.85	20.05	0.57	0.80
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	1759.10	32.84	2.34	2.61
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	511.36	17.95	3.56	6.77
oral squamous cell carcinoma cell line:SAS	10544-107H4	2073.15	20.79	3.23	5.54
osteoclastoma cell line:Hs 706.T	10704-109H2	335.12	3.53	0.59	0.29
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	638.15	28.96	0.00	1.87
osteosarcoma cell line:HS-Os-1	10558-107I9	609.88	5.94	0.42	1.27
ovary, adult, pool1	10020-101D2	609.01	3.06	0.79	0.70
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	922.83	46.56	2.38	2.75
pancreas, adult, donor1	10049-101G4	2074.11	24.46	2.82	11.29
pancreatic carcinoma cell line:NOR-P1	10698-109G5	1402.43	21.52	4.75	5.87
papillary adenocarcinoma cell line:8505C	10437-106E5	743.25	17.55	5.62	6.64
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	453.20	4.80	0.17	0.66
paracentral gyrus, adult, pool1	10035-101E8	172.98	7.23	0.09	0.46
parietal cortex, adult, donor10258	10373-105G4	329.57	5.14	0.00	0.00
parietal lobe - adult, donor10196	10171-103B9	199.38	3.76	0.00	0.94
parietal lobe, adult, donor10252	10157-103A4	116.01	3.99	0.29	1.14
parietal lobe, adult, pool1	10034-101E7	150.95	5.90	0.09	0.44
parietal lobe, fetal, donor1	10072-101I9	631.36	1.94	0.00	0.97
parietal lobe, newborn, donor10223	10356-105E5	275.53	11.22	0.00	0.00
parotid gland, adult	10199-103F1	908.35	2.47	4.32	5.55
penis, adult	10200-103F2	400.69	2.15	0.54	4.83
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	1389.13	4.46	7.07	5.58
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	1352.78	25.06	0.87	1.60
pineal gland - adult, donor10196	10179-103C8	230.27	5.16	0.00	1.29
pineal gland, adult, donor10252	10160-103A7	225.04	2.37	0.00	0.59
pineal gland, adult, donor10258	10377-105G8	244.56	6.27	0.00	0.63
pituitary gland - adult, donor10196	10180-103C9	611.13	3.04	3.04	0.00
pituitary gland, adult, donor10252	10162-103A9	394.01	5.73	0.52	0.00
pituitary gland, adult, donor10258	10378-105G9	545.65	6.81	3.40	0.85
placenta, adult, pool1	10021-101D3	229.52	2.80	0.54	0.75
plasma cell leukemia cell line:ARH-77	10840-111E3	1358.96	9.80	3.18	5.30
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	242.80	1.71	0.16	1.25
pons, adult, pool1	10033-101E6	121.44	7.57	0.09	0.09
postcentral gyrus, adult, pool1	10032-101E5	181.15	9.15	0.35	0.44
promyelocytes/myelocytes PMC, donor1	12132-128D8	422.46	35.55	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	1195.24	22.03	0.00	5.51
promyelocytes/myelocytes PMC, donor3	12140-128E7	1854.25	23.47	11.74	0.00
prostate cancer cell line:DU145	10490-107B4	778.56	42.53	1.75	2.18
prostate cancer cell line:PC-3	10439-106E7	1153.81	26.86	2.18	2.90
prostate, adult, pool1	10022-101D4	410.92	2.00	0.91	1.00
putamen, adult, donor10196	10176-103C5	170.91	2.36	0.24	1.18
putamen, adult, donor10252	10152-102I8	329.40	1.96	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	815.24	4.37	1.09	5.46
putamen, adult, donor10258, tech_rep2	10372-105G3	252.48	4.11	0.00	0.97
putamen, newborn, donor10223	10365-105F5	231.65	2.25	0.75	0.75
rectal cancer cell line:TT1TKB	10469-106I1	711.92	12.22	1.16	2.62
rectum, fetal, donor1	10067-101I4	1043.24	1.39	1.39	2.78
renal cell carcinoma cell line:OS-RC-2	10411-106B6	262.67	5.30	0.00	0.42
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	278.35	2.49	2.07	0.83
retina, adult, pool1	10030-101E3	376.62	4.27	0.50	0.70
retinoblastoma cell line:Y79	10475-106I7	762.52	10.39	2.60	1.82
rhabdomyosarcoma cell line:KYM-1	10787-110H4	826.70	48.93	0.86	2.58
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	1504.14	18.84	3.09	2.53
sacrococcigeal teratoma cell line:HTST	10695-109G2	590.37	1.52	0.76	0.76
salivary acinar cells, donor1	11771-123I7	832.43	11.98	2.27	2.59
salivary acinar cells, donor2	11772-123I8	1077.27	6.61	3.44	3.72
salivary acinar cells, donor3	11773-123I9	699.79	2.65	0.00	1.32
salivary gland, adult, pool1	10093-102C3	1279.46	1.72	2.86	1.72
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	526.53	6.91	0.42	0.76
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	551.91	5.52	1.06	1.29
seminal vesicle, adult	10201-103F3	397.86	2.65	3.17	3.17
serous adenocarcinoma cell line:JHOS-2	10639-108I9	1583.14	56.84	8.50	16.76
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	597.63	3.27	0.25	4.28
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	557.96	6.02	2.01	1.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	595.04	8.33	1.21	2.15
signet ring carcinoma cell line:Kato III	10436-106E4	476.60	9.51	0.77	1.11
signet ring carcinoma cell line:NUGC-4	10483-107A6	539.97	9.03	0.65	1.03
skeletal muscle - soleus muscle, donor1	10282-104F3	1012.22	7.09	1.42	2.13
skeletal muscle, adult, pool1	10023-101D5	537.68	5.16	1.80	1.44
skeletal muscle, fetal, donor1	10066-101I3	1358.78	3.02	4.02	9.05
skin, adult, donor1	10074-102A2	800.65	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	838.90	3.79	5.05	1.26
small cell cervical cancer cell line:HCSC-1	10800-110I8	630.02	19.01	1.33	1.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	1225.83	25.85	3.47	8.83
small cell lung carcinoma cell line:DMS 144	10841-111E4	899.17	8.67	1.16	4.43
small cell lung carcinoma cell line:LK-2	10541-107H1	1198.95	28.52	1.98	2.31
small cell lung carcinoma cell line:NCI-H82	10842-111E5	1391.03	3.22	1.45	4.66
small cell lung carcinoma cell line:WA-hT	10562-108A4	617.80	18.31	0.44	0.87
small intestine, adult, pool1	10024-101D6	355.34	7.88	0.96	1.31
small intestine, fetal, donor1	10064-101I1	540.04	2.46	1.47	1.72
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	579.58	3.08	2.56	5.64
smooth muscle, adult, pool1	10048-101G3	481.50	1.03	0.52	2.07
somatostatinoma cell line:QGP-1	10781-110G7	904.57	32.97	0.54	1.07
spinal cord - adult, donor10196	10181-103D1	214.72	1.38	0.46	0.69
spinal cord, adult, donor10252	10159-103A6	151.79	2.37	0.79	0.39
spinal cord, adult, donor10258	10369-105F9	632.30	2.08	1.38	1.38
spinal cord, fetal, donor1	10056-101H2	717.78	9.15	0.61	1.22
spinal cord, newborn, donor10223	10359-105E8	364.61	5.05	3.21	3.21
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	587.56	11.50	1.49	1.19
spleen, adult, pool1	10025-101D7	323.24	5.73	0.33	0.99
spleen, fetal, pool1	10044-101F8	413.41	3.58	0.87	1.03
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	608.13	8.80	0.41	2.28
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	342.92	6.65	0.38	0.76
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	706.24	32.50	2.10	4.19
squamous cell carcinoma cell line:T3M-5	10616-108G4	2815.49	70.76	3.91	7.82
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	506.06	21.39	0.90	0.34
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	976.40	18.21	3.39	3.39
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	734.87	12.69	0.42	1.27
stomach, fetal, donor1	10062-101H8	1177.97	11.75	3.20	4.27
submaxillary gland, adult	10202-103F4	725.20	2.28	2.85	5.70
substantia nigra - adult, donor10196	10178-103C7	162.82	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	183.20	6.44	0.62	1.87
substantia nigra, adult, donor10258	10371-105G2	485.18	3.10	0.52	0.52
substantia nigra, newborn, donor10223	10358-105E7	346.22	7.77	1.41	0.71
synovial sarcoma cell line:HS-SY-II	10441-106E9	686.65	25.22	0.92	2.52
temporal lobe, adult, pool1	10031-101E4	220.91	7.04	0.42	0.76
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	811.98	2.85	4.27	4.27
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	871.16	2.64	1.76	5.71
tenocyte, donor1	11763-123H8	616.16	3.14	2.44	2.79
tenocyte, donor2	11765-123I1	631.01	3.43	0.38	2.29
tenocyte, donor3	11768-123I4	630.87	8.15	1.11	6.30
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	1046.62	31.44	2.04	5.27
teratocarcinoma cell line:NCR-G1	10798-110I6	1359.89	25.28	4.78	5.40
teratocarcinoma cell line:PA-1	10807-111A6	914.83	33.63	0.77	2.94
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	1776.76	56.24	3.68	6.98
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	1721.82	7.19	1.89	1.51
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	2141.33	15.27	4.04	5.78
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	2337.89	62.21	24.75	26.06
testis, adult, pool1	10026-101D8	391.59	8.48	0.64	1.29
testis, adult, pool2	10096-102C6	517.85	8.12	2.71	3.16
thalamus - adult, donor10196	10168-103B6	357.69	4.42	0.00	0.00
thalamus, adult, donor10252	10154-103A1	142.84	2.81	1.25	0.63
thalamus, adult, donor10258, tech_rep1	10370-105G1	600.45	4.62	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	198.78	10.21	0.16	0.49
thalamus, newborn, donor10223	10366-105F6	215.74	5.75	0.00	0.00
throat, adult	10209-103G2	519.56	9.49	3.50	2.00
throat, fetal, donor1	10061-101H7	774.87	8.23	2.74	3.05
thymic carcinoma cell line:Ty-82	10803-111A2	1221.60	14.71	1.39	5.76
thymus, adult, pool1	10027-101D9	428.48	2.29	0.80	1.09
thymus, fetal, pool1	10043-101F7	346.73	2.49	0.52	1.25
thyroid carcinoma cell line:KHM-5M	10776-110G2	1339.45	34.17	2.93	3.86
thyroid carcinoma cell line:TCO-1	10783-110G9	1973.97	11.73	2.93	5.31
thyroid, adult, pool1	10028-101E1	539.72	5.97	1.40	2.52
thyroid, fetal, donor1	10060-101H6	455.87	4.48	1.32	0.79
tongue epidermis (fungiform papillae), donor1	10288-104F9	683.67	9.24	3.08	3.08
tongue, adult	10203-103F5	582.61	14.88	4.88	5.58
tongue, fetal, donor1	10059-101H5	683.75	20.10	2.76	1.18
tonsil, adult, pool1	10047-101G2	578.41	4.91	0.50	1.00
trachea, adult, pool1	10029-101E2	456.03	6.30	0.57	1.06
trachea, fetal, donor1	10058-101H4	775.54	8.85	3.08	5.39
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	684.11	13.11	2.13	2.48
transitional-cell carcinoma cell line:5637	10418-106C4	533.03	15.30	0.71	0.41
transitional-cell carcinoma cell line:JMSU1	10492-107B6	1126.89	8.46	2.19	3.13
tridermal teratoma cell line:HGRT	10694-109G1	683.01	7.61	1.90	5.71
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	1385.39	9.90	0.93	3.05
umbilical cord, fetal, donor1	10057-101H3	550.84	8.35	6.26	2.09
uterus, adult, pool1	10100-102D1	896.48	1.71	0.51	1.02
uterus, fetal, donor1	10055-101H1	901.51	6.66	0.00	2.05
vagina, adult	10204-103F6	575.76	1.94	3.88	1.29
vein, adult	10191-103E2	556.98	3.95	3.51	5.04
xeroderma pigentosum b cell line:XPL 17	10563-108A5	1208.07	10.68	1.87	4.01